UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-22883
ARK ETF Trust
(Exact name of registrant as specified in charter)
c/o ARK Investment Management LLC
200 Central Avenue, Suite 220
St. Petersburg, FL 33701
(Address of principal executive offices) (Zip code)
Corporation Service Company
251 Little Falls Drive
Wilmington, DE 19808
(Name and address of agent for service)
Registrant’s telephone number, including area code: (727) 810-8160
Date of fiscal year end: July 31
Date of reporting period: January 31, 2024
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 100 F Street, NE, Washington, DC 20549-1090. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Table of Contents
Item 1. Reports to Stockholders.
(a) The Report to Shareholders is attached herewith.
Table of Contents
Table of Contents | | |
| |
Table of Contents
Shareholder Letter (Unaudited) | | |
| |
Dear Shareholder:
ARK Investment Management LLC (“ARK” or the “Adviser”), the investment adviser to the ARK ETF Trust (the “ARK ETFs”) specializes in thematic investing in disruptive innovation. The ARK ETFs include portfolio companies that we believe are leading and benefiting from five innovation platforms: artificial intelligence (“AI”), energy storage, robotics, multiomic sequencing, and blockchain technology. These platforms involve 14 technologies, including neural networks, multiomic technologies, autonomous mobility, and cryptocurrencies. According to ARK’s research, these five innovation platforms are, in our view, converging to create unprecedented growth trajectories. AI is the most important catalyst, its velocity cascading through all other technologies. The market value of disruptive innovation platforms could scale 42% at an annual rate during this business cycle, from $19 trillion today to $220 trillion by 2030.1 In 2030, the market value associated with disruptive innovation could account for the majority of the global equity market capitalization.
In 2023, in particular the fourth quarter, investment strategies focused on disruptive innovation performed quite well, buoyed in part by the growing consensus that the U.S. Federal Reserve (Fed) will lower interest rates in 2024. In response to an unprecedented 24-fold hike in interest rates over 17 months, corporations seem to be losing pricing power and are beginning to downsize, which could cause a harder-than-expected landing. During the past two years, the U.S. economy seems to have been in a rolling recession that has depressed housing, autos, and commercial real estate, while inventories have continued to build in the aftermath of the double- and triple-ordering that took place in response to supply chain bottlenecks from 2020 through 2022. As inflation gives way to broad based deflation during the next year, companies associated with ARK’s Five Innovation Platforms could play an outsized role in salvaging corporate profit margins. Innovation solves problems!
While the bear market in 2022 punished companies investing aggressively to capitalize on technology breakthroughs, innovation continued apace in 2023 thanks to advances in artificial intelligence (AI), blockchain technology, multiomic technologies, robotics, and energy storage. Early last year, OpenAI’s GPT-4 unleashed the power of AI by achieving top-percentile scores across a range of standardized tests from law to calculus. On the Uniform Bar Exam, it scored in the 90th percentile, a leap from GPT-3.5’s 10th percentile in 2022.
As a reminder, bitcoin’s price appreciated 40%+ during the U.S. regional bank crisis of 2023, validating its role as an insurance policy against central points of failure in the U.S. and European banking systems. Indeed, since the peak of the FTX-related crisis in 2022, the Bitcoin network has not skipped a beat, facilitating $3.6 trillion in approximately 163 million transactions, issuing approximately 373,000 new bitcoin, and attracting approximately 187 million new addresses. Moreover, bitcoin continued to rally throughout the year as the SEC prepared to approve 11 spot Bitcoin ETFs in early 2024.
On December 8, 2023, the Food and Drug Administration (FDA) approved the first gene-editing therapy in the U.S. Developed and manufactured by CRISPR Therapeutics and Vertex Pharmaceuticals, Casgevy will treat patients with severe Sickle Cell Disease (SCD) and beta thalassemia. In our view, companies sacrificing short-term profitability to invest aggressively in innovative technologies should enjoy exponential and highly profitable long-term growth opportunities.
Moreover, innovation should be a source of good deflation, as learning curves cut costs and increase productivity. Yet, many legacy companies that have catered to risk-averse short-term oriented shareholders have leveraged their balance sheets to buy back stock, bolster earnings, and increase dividends. In so doing, many have curtailed research and development (R&D) and capital spending and, now, could be ill-prepared for the potential disintermediation associated with disruptive innovation. For these and other reasons, we believe disruptive innovation taking place outside the remit of broad-based equity benchmarks could transform the playing field in 2024 and beyond.
As such, it may be prudent to complement, hedge, or diversify core benchmark exposures by investing in alternative public equity exposures. Since 2014, with tech-specific domain expertise, ARK analysts have focused on the industries, companies, and stocks that ARK believes are likely to be prime beneficiaries of the AI revolution. Given ARK analysts’ understanding of hardware, software, and applications, ARK portfolios offer significant exposure to the AI opportunity.
1
Table of Contents
Shareholder Letter (concluded) (Unaudited) | | |
| |
On the following pages, you will find information relating to your ARK ETF investment. If you have any questions, I encourage you to contact your financial advisor or ARK directly. You can find additional information, including our daily portfolio holdings, on the ARK ETF website located at: www.ark-funds.com.
We appreciate the opportunity to help you meet your investment goals and thank you for enabling us to invest for you at the pace of innovation!
Sincerely,
Catherine D. Wood
Chief Investment Officer and Chief Executive Officer
ARK Investment Management LLC
2
Table of Contents
Shareholder Expense Examples (Unaudited) | | |
| |
As a shareholder of an ARK ETF (each, a “Fund” and collectively, “Funds”) you incur two types of costs: (1) transaction costs for purchasing and selling shares; and (2) ongoing costs, including management fees and other Fund expenses. The following examples are intended to help you understand your ongoing costs (in dollars and cents) of investing in the Funds and to compare these costs with the ongoing costs of investing in other funds.
The examples below are based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (August 1, 2023 through January 31, 2024).
Actual Expenses
The first line under each Fund in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Fund under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during the period.
Hypothetical Example for Comparison Purposes
The second line under each Fund in the table below provides information about hypothetical account values and hypothetical expenses based on each Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate your actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund to other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of Fund shares. Therefore, the second line under each Fund in the table is useful in comparing ongoing Fund costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
| Beginning Account Value 8/1/2023 | Ending Account Value 1/31/2024 | Annualized Expense Ratios Based on the Six-Month Period | Expenses Paid During the Six-Month Period* |
ARK Genomic Revolution ETF | | | | |
Actual | $1,000.00 | $750.70 | 0.75% | $3.30 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.37 | 0.75% | $3.81 |
ARK Autonomous Technology & Robotics ETF | | | | |
Actual | $1,000.00 | $892.20 | 0.75% | $3.57 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.37 | 0.75% | $3.81 |
ARK Innovation ETF | | | | |
Actual | $1,000.00 | $901.10 | 0.75% | $3.58 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.37 | 0.75% | $3.81 |
ARK Next Generation Internet ETF | | | | |
Actual | $1,000.00 | $1,034.40 | 0.75% | $3.84 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.37 | 0.75% | $3.81 |
ARK Fintech Innovation ETF | | | | |
Actual | $1,000.00 | $1,058.30 | 0.75% | $3.88 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.37 | 0.75% | $3.81 |
ARK Space Exploration & Innovation ETF | | | | |
Actual | $1,000.00 | $916.30 | 0.72% | $3.47 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.52 | 0.72% | $3.66 |
The 3D Printing ETF | | | | |
Actual | $1,000.00 | $903.00 | 0.66% | $3.16 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,021.82 | 0.66% | $3.35 |
ARK Israel Innovative Technology ETF | | | | |
Actual | $1,000.00 | $972.70 | 0.49% | $2.43 |
Hypothetical (5% return before expenses) | $1,000.00 | $1,022.67 | 0.49% | $2.49 |
3
Table of Contents
Sector Diversification (as a percentage of total investments) January 31, 2024 (Unaudited) | | |
| |
4
Table of Contents
Sector Diversification (as a percentage of total investments) (concluded) January 31, 2024 (Unaudited) | | |
| |
5
Table of Contents
Schedule of Investments ARK Genomic Revolution ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 99.7% |
Biotechnology – 60.3% | | | | | |
Absci Corp.* | | 430,916 | | $ | 1,706,427 |
Amgen, Inc. | | 28,490 | | | 8,953,268 |
Arcturus Therapeutics Holdings, Inc.*† | | 1,738,717 | | | 57,325,500 |
Beam Therapeutics, Inc.* | | 2,204,760 | | | 53,796,144 |
CareDx, Inc.*† | | 6,033,617 | | | 51,647,761 |
Compass Pathways PLC (United Kingdom)*(a) | | 2,223,490 | | | 25,058,732 |
CRISPR Therapeutics AG (Switzerland)* | | 1,736,173 | | | 109,292,090 |
Exact Sciences Corp.* | | 2,069,857 | | | 135,368,648 |
Incyte Corp.* | | 451,315 | | | 26,523,783 |
Intellia Therapeutics, Inc.* | | 2,073,352 | | | 49,387,245 |
Ionis Pharmaceuticals, Inc.* | | 1,471,354 | | | 75,612,882 |
Moderna, Inc.* | | 348,084 | | | 35,173,888 |
Nurix Therapeutics, Inc.*† | | 2,710,369 | | | 21,411,915 |
Prime Medicine, Inc.* | | 2,522,247 | | | 16,016,269 |
Recursion Pharmaceuticals, Inc., Class A* | | 8,614,106 | | | 81,058,737 |
Regeneron Pharmaceuticals, Inc.* | | 21,479 | | | 20,249,972 |
Repare Therapeutics, Inc. (Canada)*† | | 2,750,042 | | | 17,985,275 |
Senti Biosciences, Inc.* | | 1,905,324 | | | 857,586 |
Twist Bioscience Corp.* | | 2,662,495 | | | 86,264,838 |
Veracyte, Inc.* | | 1,941,183 | | | 48,568,399 |
Vertex Pharmaceuticals, Inc.* | | 100,707 | | | 43,644,400 |
Verve Therapeutics, Inc.* | | 2,912,709 | | | 31,515,511 |
Total Biotechnology | | | | | 997,419,270 |
Chemicals – 3.7% | | | | | |
Ginkgo Bioworks Holdings, Inc.* | | 50,199,129 | | | 60,740,946 |
Electronic Equipment, Instruments & Components – 1.6% |
908 Devices, Inc.*† | | 3,644,629 | | | 25,803,973 |
Health Care Equipment & Supplies – 1.3% |
Butterfly Network, Inc.*† | | 11,621,014 | | | 10,471,695 |
Cerus Corp.* | | 5,913,672 | | | 10,703,746 |
Total Health Care Equipment & Supplies | | | | | 21,175,441 |
Health Care Providers & Services – 4.6% | | | | | |
Accolade, Inc.*† | | 5,773,197 | | | 65,352,590 |
Guardant Health, Inc.* | | 371,516 | | | 8,147,346 |
Invitae Corp.* | | 8,354,015 | | | 3,258,066 |
Total Health Care Providers & Services | | | | | 76,758,002 |
Health Care Technology – 11.0% | | | | | |
Schrodinger, Inc.* | | 2,590,832 | | | 68,527,506 |
Teladoc Health, Inc.* | | 3,773,575 | | | 73,320,562 |
Veeva Systems, Inc., Class A* | | 192,424 | | | 39,910,662 |
Total Health Care Technology | | | | | 181,758,730 |
Investments | | Shares | | Value |
Life Sciences Tools & Services – 13.6% |
10X Genomics, Inc., Class A* | | 1,296,562 | | $ | 54,027,739 |
Adaptive Biotechnologies Corp.*† | | 10,871,678 | | | 39,899,058 |
Pacific Biosciences of California, Inc.* | | 11,216,232 | | | 73,017,670 |
Personalis, Inc.*† | | 5,594,307 | | | 7,496,372 |
Quantum-Si, Inc.*† | | 13,137,145 | | | 20,493,946 |
Standard Biotools, Inc.* | | 13,415,701 | | | 30,453,641 |
Total Life Sciences Tools & Services | | | | | 225,388,426 |
Pharmaceuticals – 0.2% |
Pfizer, Inc. | | 118,286 | | | 3,203,185 |
Semiconductors & Semiconductor Equipment – 1.2% |
NVIDIA Corp. | | 33,157 | | | 20,400,507 |
Software – 2.2% |
UiPath, Inc., Class A* | | 1,600,220 | | | 36,773,056 |
Total Common Stocks (Cost $5,326,384,169) | | | | | 1,649,421,536 |
MONEY MARKET FUND – 0.1% |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(b) (Cost $2,158,025) | | 2,158,025 | | | 2,158,025 |
Total Investments – 99.8% (Cost $5,328,542,194) | | | | | 1,651,579,561 |
Other Assets in Excess of Liabilities – 0.2% | | | | | 3,428,149 |
Net Assets – 100.0% | | | | $ | 1,655,007,710 |
See accompanying Notes to Financial Statements.
6
Table of Contents
Schedule of Investments (continued) ARK Genomic Revolution ETF | | |
January 31, 2024 (Unaudited) | | |
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2023 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 1/31/2024 | Value ($) at 1/31/2024 |
Common Stocks — 19.2% |
Biotechnology — 9.0% |
Arcturus Therapeutics Holdings, Inc. |
68,837,324 | 14,331,214 | (21,617,847) | (1,802,147) | (2,423,044) | — | — | 1,738,717 | 57,325,500 |
CareDx, Inc. |
75,455,294 | 16,977,404 | (24,404,603) | (4,409,929) | (11,970,405) | — | — | 6,033,617 | 51,647,761 |
Compass Pathways PLC^ |
23,469,503 | 5,036,059 | (7,893,815) | 68,680 | 4,378,305 | — | — | 2,223,490 | 25,058,732 |
Nurix Therapeutics, Inc. |
22,662,383 | 11,788,641 | (8,960,471) | 934,968 | (5,013,606) | — | — | 2,710,369 | 21,411,915 |
Repare Therapeutics, Inc. |
24,961,228 | 7,657,831 | (7,470,757) | (650,828) | (6,512,199) | — | — | 2,750,042 | 17,985,275 |
Twist Bioscience Corp.^ |
72,213,227 | 23,197,063 | (31,893,549) | 3,420,267 | 19,327,830 | — | — | 2,662,495 | 86,264,838 |
Electronic Equipment, Instruments & Components — 1.6% |
908 Devices, Inc. |
28,538,589 | 9,076,997 | (11,199,117) | (1,360,507) | 748,011 | — | — | 3,644,629 | 25,803,973 |
Health Care Equipment & Supplies — 0.6% |
Butterfly Network, Inc. |
33,824,279 | 4,022,379 | (5,972,001) | (1,568,681) | (19,834,281) | — | — | 11,621,014 | 10,471,695 |
Health Care Providers & Services — 3.9% |
Accolade, Inc. |
89,210,554 | 24,106,739 | (27,914,217) | 1,933,906 | (21,984,392) | — | — | 5,773,197 | 65,352,590 |
Health Care Technology — 0.0% |
Schrodinger, Inc.^ |
183,463,620 | 25,659,768 | (54,139,834) | (24,064,275) | (62,391,773) | — | — | 2,590,832 | 68,527,506 |
Life Sciences Tools & Services — 4.1% |
Adaptive Biotechnologies Corp. |
93,226,864 | 23,306,420 | (22,238,592) | (2,094,964) | (52,300,670) | — | — | 10,871,678 | 39,899,058 |
Codexis, Inc.^ |
12,541,558 | 120,195 | (6,342,749) | (62,218,482) | 55,899,478 | — | — | — | — |
Personalis, Inc. |
13,973,286 | 2,900,045 | (3,607,839) | (67,451) | (5,701,669) | — | — | 5,594,307 | 7,496,372 |
Quantum-Si, Inc. |
57,609,356 | 7,302,002 | (10,004,523) | (155,437) | (34,257,452) | — | — | 13,137,145 | 20,493,946 |
SomaLogic, Inc.^ |
32,105,075 | 9,611,802 | (123,265,543) | (63,466) | 81,612,132 | — | — | — | — |
Standard Biotools, Inc.^ |
— | 116,446,198 | (5,134,989) | (153,170) | (80,704,398) | — | — | 13,415,701 | 30,453,641 |
$832,092,140 | $301,540,757 | $(372,060,446) | $(92,251,516) | $(141,128,133) | $ — | $ — | 84,767,233 | $528,192,802 |
See accompanying Notes to Financial Statements.
7
Table of Contents
Schedule of Investments (continued) ARK Genomic Revolution ETF | | |
January 31, 2024 (Unaudited) | | |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Genomic Revolution ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $1,649,421,536 | $ — | $ — | $1,649,421,536 |
Money Market Fund | 2,158,025 | — | — | 2,158,025 |
Total | $1,651,579,561 | $ — | $ — | $1,651,579,561 |
See accompanying Notes to Financial Statements.
8
Table of Contents
Schedule of Investments ARK Autonomous Technology & Robotics ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 99.8% | | | | | |
Aerospace & Defense – 20.7% | | | | | |
AeroVironment, Inc.* | | 318,110 | | $ | 38,376,791 |
Archer Aviation, Inc., Class A* | | 7,420,110 | | | 35,839,131 |
Elbit Systems Ltd. (Israel) | | 75,275 | | | 15,566,870 |
Kratos Defense & Security Solutions, Inc.* | | 4,464,085 | | | 75,576,959 |
Lockheed Martin Corp. | | 21,972 | | | 9,434,997 |
Rocket Lab USA, Inc.* | | 3,542,384 | | | 17,180,562 |
Total Aerospace & Defense | | | | | 191,975,310 |
Automobile Components – 1.8% | | | | | |
Magna International, Inc. (Canada) | | 298,901 | | | 16,992,522 |
Automobiles – 11.1% | | | | | |
BYD Co. Ltd. (China)(a) | | 171,286 | | | 7,694,167 |
Tesla, Inc.* | | 508,939 | | | 95,319,185 |
Total Automobiles | | | | | 103,013,352 |
Diversified Consumer Services – 0.1% | | | | | |
2U, Inc.* | | 654,477 | | | 556,764 |
Diversified Telecommunication – 7.1% | | | | | |
Iridium Communications, Inc. | | 1,828,675 | | | 66,307,756 |
Electronic Equipment, Instruments & Components – 9.0% |
Teledyne Technologies, Inc.* | | 29,422 | | | 12,312,224 |
Trimble, Inc.* | | 1,327,490 | | | 67,516,142 |
Vuzix Corp.* | | 2,366,666 | | | 3,952,332 |
Total Electronic Equipment, Instruments & Components | | | | | 83,780,698 |
Health Care Equipment & Supplies – 1.7% | | | |
Intuitive Surgical, Inc.* | | 40,535 | | | 15,331,148 |
Interactive Media & Services – 2.5% | | | | | |
Alphabet, Inc., Class C* | | 165,158 | | | 23,419,404 |
Machinery – 11.6% | | | | | |
3D Systems Corp.* | | 1,757,291 | | | 8,417,424 |
Caterpillar, Inc. | | 63,884 | | | 19,185,004 |
Deere & Co. | | 87,058 | | | 34,264,288 |
Komatsu Ltd. (Japan)(a) | | 1,269,256 | | | 36,072,255 |
Markforged Holding Corp.*† | | 11,280,629 | | | 7,638,114 |
Stratasys Ltd.* | | 5,948 | | | 78,633 |
Velo3D, Inc.* | | 7,564,898 | | | 2,371,595 |
Total Machinery | | | | | 108,027,313 |
Oil, Gas & Consumable Fuels – 1.6% | | | | | |
Cameco Corp. (Canada) | | 311,766 | | | 14,886,826 |
Passenger Airlines – 2.8% | | | | | |
Blade Air Mobility, Inc.*† | | 4,760,135 | | | 14,185,202 |
Joby Aviation, Inc.* | | 2,200,637 | | | 12,015,478 |
Total Passenger Airlines | | | | | 26,200,680 |
Investments | | Shares | | Value |
Semiconductors & Semiconductor Equipment – 14.9% | | | | |
Advanced Micro Devices, Inc.* | | 107,908 | | $ | 18,095,093 | |
NVIDIA Corp. | | 49,914 | | | 30,710,587 | |
QUALCOMM, Inc. | | 35,337 | | | 5,247,898 | |
Taiwan Semiconductor Manufacturing Co. Ltd. (Taiwan)(a) | | 184,241 | | | 20,811,863 | |
Teradyne, Inc. | | 659,170 | | | 63,669,230 | |
Total Semiconductors & Semiconductor Equipment | | | | | 138,534,671 | |
Software – 14.9% | | | | | | |
ANSYS, Inc.* | | 38,078 | | | 12,483,111 | |
Materialise NV (Belgium)*(a) | | 948,124 | | | 5,375,863 | |
Synopsys, Inc.* | | 28,376 | | | 15,134,339 | |
UiPath, Inc., Class A* | | 3,817,129 | | | 87,717,624 | |
Unity Software, Inc.* | | 537,969 | | | 17,430,196 | |
Total Software | | | | | 138,141,133 | |
Total Common Stocks (Cost $1,425,290,020) | | | | | 927,167,577 | |
MONEY MARKET FUND – 0.2% | | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund 5.21%(b) (Cost $2,228,590) | | 2,228,590 | | | 2,228,590 | |
Total Investments – 100.0% (Cost $1,427,518,610) | | | | | 929,396,167 | |
Liabilities in Excess of Other Assets – (0.0)%(c) | | | (386,625 | ) |
Net Assets – 100.0% | | | | $ | 929,009,542 | |
See accompanying Notes to Financial Statements.
9
Table of Contents
Schedule of Investments (continued) ARK Autonomous Technology & Robotics ETF | | |
January 31, 2024 (Unaudited) | | |
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2023 |
Purchases Cost ($)
|
Sales Proceeds ($)
|
Net Realized Gain/(Loss) ($)
| Net Change in Unrealized Appreciation (Depreciation) ($) |
Dividend Income ($)
|
Capital Gain Distributions ($)
|
Number of Shares at 1/31/2024
|
Value ($) at 1/31/2024
|
Common Stocks — 2.3% | | | | | | | | |
Machinery — 0.8% | | | | | | | | |
Markforged Holding Corp. | | | | | | | | |
24,905,366 | 1,033,667 | (1,420,428) | (223,169) | (16,657,322) | — | — | 11,280,629 | 7,638,114 |
Passenger Airlines — 1.5% | | | | | | | | |
Blade Air Mobility, Inc. | | | | | | | | |
22,198,478 | 141,557 | (1,790,309) | (1,769,253) | (4,595,271) | — | — | 4,760,135 | 14,185,202 |
$47,103,844 | $1,175,224 | $(3,210,737) | $(1,992,422) | $(21,252,593) | $ — | $ — | 16,040,764 | $21,823,316 |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Autonomous Technology & Robotics ETF | |
Level 1
| |
Level 2
| |
Level 3
| |
Total
|
Assets | | | | | | | | |
Common Stocks‡ | | $927,167,577 | | $ — | | $ — | | $927,167,577 |
Money Market Fund | | 2,228,590 | | — | | — | | 2,228,590 |
Total | | $929,396,167 | | $ — | | $ — | | $929,396,167 |
See accompanying Notes to Financial Statements.
10
Table of Contents
Schedule of Investments ARK Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 99.9% | | | | | |
Aerospace & Defense – 0.8% | | | | | |
Archer Aviation, Inc., Class A*† | | 12,999,367 | | $ | 62,786,943 |
Automobiles – 8.0% | | | | | |
Tesla, Inc.* | | 3,203,328 | | | 599,951,301 |
Biotechnology – 16.3% | | | | | |
Beam Therapeutics, Inc.*† | | 6,000,363 | | | 146,408,857 |
CRISPR Therapeutics AG (Switzerland)*† | | 5,984,984 | | | 376,754,743 |
Exact Sciences Corp.* | | 2,296,932 | | | 150,219,353 |
Intellia Therapeutics, Inc.*† | | 7,517,816 | | | 179,074,377 |
Recursion Pharmaceuticals, Inc., Class A*† | | 12,877,053 | | | 121,173,069 |
Twist Bioscience Corp.*† | | 3,491,286 | | | 113,117,666 |
Veracyte, Inc.*† | | 4,070,762 | | | 101,850,465 |
Verve Therapeutics, Inc.* | | 3,086,708 | | | 33,398,180 |
Total Biotechnology | | | | | 1,221,996,710 |
Capital Markets – 11.8% | | | | | |
Coinbase Global, Inc., Class A* | | 5,233,526 | | | 670,938,033 |
Robinhood Markets, Inc., Class A* | | 20,292,596 | | | 217,942,481 |
Total Capital Markets | | | | | 888,880,514 |
Chemicals – 2.0% | | | | | |
Ginkgo Bioworks Holdings, Inc.*† | | 123,410,876 | | | 149,327,160 |
Diversified Consumer Services – 0.1% | | | | | |
2U, Inc.*† | | 6,246,665 | | | 5,314,038 |
Entertainment – 12.0% | | | | | |
ROBLOX Corp., Class A* | | 8,160,341 | | | 316,702,834 |
Roku, Inc.*† | | 6,675,396 | | | 587,835,372 |
Total Entertainment | | | | | 904,538,206 |
Financial Services – 6.3% | | | | | |
Block, Inc.* | | 7,294,940 | | | 474,244,049 |
Health Care Equipment & Supplies – 0.3% |
Cerus Corp.*† | | 12,717,509 | | | 23,018,691 |
Health Care Providers & Services – 0.1% | | | |
Invitae Corp.*† | | 18,151,368 | | | 7,079,034 |
Health Care Technology – 3.1% | | | | | |
Teladoc Health, Inc.*† | | 11,841,315 | | | 230,076,750 |
Hotels, Restaurants & Leisure – 3.4% | | | | | |
DraftKings, Inc., Class A* | | 6,476,449 | | | 252,905,334 |
Interactive Media & Services – 1.4% | | | | | |
Meta Platforms, Inc., Class A* | | 200,043 | | | 78,044,776 |
Pinterest, Inc., Class A* | | 744,340 | | | 27,890,420 |
Total Interactive Media & Services | | | | | 105,935,196 |
IT Services – 7.3% | | | | | |
Shopify, Inc., Class A (Canada)* | | 3,438,995 | | | 275,360,330 |
Twilio, Inc., Class A* | | 3,888,253 | | | 273,460,833 |
Total IT Services | | | | | 548,821,163 |
Investments | | Shares | | Value |
Life Sciences Tools & Services – 3.4% | | | | | | |
10X Genomics, Inc., Class A* | | 3,255,116 | | $ | 135,640,684 | |
Pacific Biosciences of California, Inc.*† | | 18,508,246 | | | 120,488,681 | |
Total Life Sciences Tools & Services | | | | | 256,129,365 | |
Media – 1.4% | | | | | | |
Trade Desk, Inc. (The), Class A* | | 1,527,179 | | | 104,504,859 | |
Semiconductors & Semiconductor Equipment – 1.0% | | | | |
Teradyne, Inc. | | 799,942 | | | 77,266,398 | |
Software – 21.2% | | | | | | |
PagerDuty, Inc.*† | | 7,534,053 | | | 178,406,375 | |
Palantir Technologies, Inc., Class A* | | 8,210,888 | | | 132,113,188 | |
UiPath, Inc., Class A* | | 21,133,656 | | | 485,651,415 | |
Unity Software, Inc.* | | 8,328,552 | | | 269,845,085 | |
Zoom Video Communications, Inc., Class A* | | 8,066,031 | | | 521,146,263 | |
Total Software | | | | | 1,587,162,326 | |
Total Common Stocks (Cost $16,502,458,212) | | | | | 7,499,938,037 | |
MONEY MARKET FUND – 0.2% | | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(a) (Cost $15,420,867) | | 15,420,867 | | | 15,420,867 | |
Total Investments – 100.1% (Cost $16,517,879,079) | | | | | 7,515,358,904 | |
Liabilities in Excess of Other Assets – (0.1)% | | | (11,110,783 | ) |
Net Assets – 100.0% | | | | $ | 7,504,248,121 | |
See accompanying Notes to Financial Statements.
11
Table of Contents
Schedule of Investments (continued) ARK Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2023 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 1/31/2024 | Value ($) at 1/31/2024 |
Common Stocks — 32.0% |
Aerospace & Defense — 0.8% |
Archer Aviation, Inc. |
— | 121,459,761 | (46,721,360) | 3,354,965 | (15,306,423) | — | — | 12,999,367 | 62,786,943 |
Biotechnology — 13.8% |
Beam Therapeutics, Inc. | | | | | | | |
187,666,293 | 110,330,450 | (114,197,188) | 578,322 | (37,969,020) | — | — | 6,000,363 | 146,408,857 |
CRISPR Therapeutics AG | | | | | | | |
302,287,216 | 260,428,162 | (224,871,904) | 14,374,708 | 24,536,561 | — | — | 5,984,984 | 376,754,743 |
Intellia Therapeutics, Inc. | | | | | | | |
286,103,983 | 189,170,348 | (167,536,687) | 1,365,851 | (130,029,118) | — | — | 7,517,816 | 179,074,377 |
Recursion Pharmaceuticals, Inc. | | | | | | | |
— | 129,753,506 | (28,981,017) | 10,101,709 | 10,298,871 | — | — | 12,877,053 | 121,173,069 |
Twist Bioscience Corp. |
90,859,200 | 58,171,254 | (66,493,577) | (200,421) | 30,781,210 | — | — | 3,491,286 | 113,117,666 |
Veracyte, Inc. | | | | | | | |
124,735,243 | 66,681,370 | (78,461,968) | (3,523,856) | (7,580,324) | — | — | 4,070,762 | 101,850,465 |
Chemicals — 2.0% | | | | | | | |
Ginkgo Bioworks Holdings, Inc. | | | | | | | |
288,528,574 | 156,816,423 | (143,967,030) | 8,423,140 | (160,473,947) | — | — | 123,410,876 | 149,327,160 |
Diversified Consumer Services — 0.1% |
2U, Inc. |
28,757,020 | 10,491,081 | (9,279,415) | (884,659) | (23,769,989) | — | — | 6,246,665 | 5,314,038 |
Entertainment — 7.8% |
Roku, Inc. |
875,800,633 | 421,144,015 | (630,589,377) | (468,102,331) | 389,582,432 | — | — | 6,675,396 | 587,835,372 |
Health Care Equipment & Supplies — 0.3% |
Cerus Corp. |
41,127,633 | 15,256,218 | (16,810,706) | (686,302) | (15,868,152) | — | — | 12,717,509 | 23,018,691 |
Health Care Providers & Services — 0.1% |
Invitae Corp. |
27,488,455 | 8,829,700 | (9,514,036) | (986,486) | (18,738,599) | — | — | 18,151,368 | 7,079,034 |
Health Care Technology — 3.1% |
Teladoc Health, Inc. |
365,234,882 | 165,881,230 | (178,186,433) | 805,389 | (123,658,318) | — | — | 11,841,315 | 230,076,750 |
Life Sciences Tools & Services — 1.6% |
Pacific Biosciences of California, Inc. |
189,323,805 | 149,211,303 | (112,352,629) | 5,826,006 | (111,519,804) | — | — | 18,508,246 | 120,488,681 |
Software — 2.4% |
PagerDuty, Inc. |
213,407,887 | 137,554,738 | (157,855,295) | (9,951,113) | (4,749,842) | — | — | 7,534,053 | 178,406,375 |
UiPath, Inc.^ |
522,311,927 | 333,837,910 | (505,129,080) | (209,818,130) | 344,448,788 | — | — | 21,133,656 | 485,651,415 |
$3,543,632,751 | $2,335,017,469 | $(2,490,947,702) | $(649,323,208) | $149,984,326 | $ — | $ — | 279,160,715 | $2,888,363,636 |
See accompanying Notes to Financial Statements.
12
Table of Contents
Schedule of Investments (continued) ARK Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Innovation ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $7,499,938,037 | $ — | $ — | $7,499,938,037 |
Money Market Fund | 15,420,867 | — | — | 15,420,867 |
Total | $7,515,358,904 | $ — | $ — | $7,515,358,904 |
See accompanying Notes to Financial Statements.
13
Table of Contents
Schedule of Investments ARK Next Generation Internet ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 92.7% | | | | | |
Automobiles – 5.4% | | | | | |
Tesla, Inc.* | | 439,984 | | $ | 82,404,603 |
Banks – 0.8% | | | | | |
NU Holdings Ltd., Class A (Brazil)* | | 1,360,437 | | | 11,713,363 |
Biotechnology – 1.1% | | | | | |
Veracyte, Inc.* | | 676,187 | | | 16,918,199 |
Broadline Retail – 1.3% | | | | | |
MercadoLibre, Inc. (Brazil)* | | 12,008 | | | 20,555,415 |
Capital Markets – 13.2% | | | | | |
Coinbase Global, Inc., Class A* | | 1,042,818 | | | 133,689,267 |
Robinhood Markets, Inc., Class A* | | 6,328,136 | | | 67,964,181 |
Total Capital Markets | | | | | 201,653,448 |
Diversified Consumer Services – 0.1% |
2U, Inc.* | | 1,185,844 | | | 1,008,798 |
Electronic Equipment Instruments & Components – 0.4% |
Vuzix Corp.*† | | 3,168,037 | | | 5,290,622 |
Entertainment – 13.8% | | | | | |
ROBLOX Corp., Class A* | | 1,618,565 | | | 62,816,507 |
Roku, Inc.* | | 1,446,399 | | | 127,369,896 |
Spotify Technology SA* | | 96,251 | | | 20,727,653 |
Total Entertainment | | | | | 210,914,056 |
Financial Services – 10.0% | | | | | |
Adyen NV (Netherlands)*(a) | | 1,519,909 | | | 19,059,659 |
Block, Inc.* | | 1,849,056 | | | 120,207,130 |
Toast, Inc., Class A* | | 728,652 | | | 12,948,146 |
Total Financial Services | | | | | 152,214,935 |
Health Care Technology – 2.2% | | | | | |
Teladoc Health, Inc.* | | 1,725,571 | | | 33,527,845 |
Hotels, Restaurants & Leisure – 7.2% |
DraftKings, Inc., Class A* | | 1,658,200 | | | 64,752,710 |
Genius Sports Ltd. (United Kingdom)* | | 6,616,371 | | | 44,395,849 |
Total Hotels, Restaurants & Leisure | | | | | 109,148,559 |
Interactive Media & Services – 3.3% |
Meta Platforms, Inc., Class A* | | 73,684 | | | 28,747,076 |
Nextdoor Holdings, Inc.*† | | 10,132,504 | | | 15,401,406 |
Pinterest, Inc., Class A* | | 167,207 | | | 6,265,246 |
Total Interactive Media & Services | | | | | 50,413,728 |
IT Services – 7.8% | | | | | |
Cloudflare, Inc., Class A* | | 414,019 | | | 32,728,202 |
Shopify, Inc., Class A (Canada)* | | 561,303 | | | 44,943,531 |
Twilio, Inc., Class A* | | 578,994 | | | 40,720,648 |
Total IT Services | | | | | 118,392,381 |
Investments | | Shares | | Value |
Media – 1.5% | | | | | | |
Trade Desk, Inc. (The), Class A* | | 327,357 | | $ | 22,401,040 | |
Semiconductors & Semiconductor Equipment – 3.1% | |
Advanced Micro Devices, Inc.* | | 94,787 | | | 15,894,832 | |
NVIDIA Corp. | | 26,571 | | | 16,348,339 | |
QUALCOMM, Inc. | | 57,055 | | | 8,473,238 | |
Taiwan Semiconductor Manufacturing Co. Ltd. (Taiwan)(a) | | 56,225 | | | 6,351,176 | |
Total Semiconductors & Semiconductor Equipment | | | | | 47,067,585 | |
Software – 20.3% | | | | | | |
Crowdstrike Holdings, Inc., Class A* | | 107,530 | | | 31,452,525 | |
Microsoft Corp. | | 40,017 | | | 15,909,959 | |
PagerDuty, Inc.* | | 1,248,275 | | | 29,559,152 | |
Palantir Technologies, Inc., Class A* | | 1,439,261 | | | 23,157,710 | |
UiPath, Inc., Class A* | | 2,848,698 | | | 65,463,080 | |
Unity Software, Inc.* | | 1,950,911 | | | 63,209,516 | |
Zoom Video Communications, Inc., Class A* | | 1,239,233 | | | 80,066,844 | |
Total Software | | | | | 308,818,786 | |
Technology Hardware, Storage & Peripherals – 1.2% | |
Pure Storage, Inc., Class A* | | 457,161 | | | 18,281,868 | |
Total Common Stocks (Cost $2,595,805,563) | | | | | 1,410,725,231 | |
EXCHANGE – TRADED FUNDS – 7.3% | |
Financials – 7.3% | | | | | | |
ARK 21Shares Active Bitcoin Futures Strategy ETF† | | 18,796 | | | 791,121 | |
ARK 21Shares Bitcoin ETF† | | 2,480,644 | | | 105,551,402 | |
Proshares Bitcoin Strategy ETF | | 286,475 | | | 5,878,467 | |
Total Financials | | | | | 112,220,990 | |
Total Exchange – Traded Funds (Cost $108,551,096) | | | | | 112,220,990 | |
MONEY MARKET FUND – 0.3% | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(b) (Cost $4,186,792) | | 4,186,792 | | | 4,186,792 | |
Total Investments – 100.3% (Cost $2,708,543,451) | | | | | 1,527,133,013 | |
Liabilities in Excess of Other Assets – (0.3)% | | | (4,097,375 | ) |
Net Assets – 100.0% | | | | $ | 1,523,035,638 | |
See accompanying Notes to Financial Statements.
14
Table of Contents
Schedule of Investments (continued) ARK Next Generation Internet ETF | | |
January 31, 2024 (Unaudited) | | |
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2023 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 1/31/2024 | Value ($) at 1/31/2024 |
Exchange — Traded Funds — 7.0% |
Financials — 7.0% |
ARK 21Shares Active Bitcoin Futures Strategy ETF |
— | 867,329 | (51,082) | (1,131) | (23,995) | 3,437 | — | 18,796 | 791,121 |
ARK 21Shares Bitcoin ETF |
— | 101,659,844 | — | — | 3,891,558 | — | — | 2,480,644 | 105,551,402 |
Common Stocks — 1.4% |
Electronic Equipment Instruments & Components – 0.4% |
Vuzix Corp. |
19,329,832 | 820,915 | (2,418,556) | (6,263,684) | (6,177,885) | — | — | 3,168,037 | 5,290,622 |
Interactive Media & Services — 1.0% |
Nextdoor Holdings, Inc. |
22,546,330 | 7,509,677 | (2,634,033) | 51,814 | (12,072,382) | — | — | 10,132,504 | 15,401,406 |
$41,876,162 | $110,857,765 | $(5,103,671) | $(6,213,001) | $(14,382,704) | $3,437 | $ — | 15,979,981 | $127,034,551 |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Next Generation Internet ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $1,410,725,231 | $ — | $ — | $1,410,725,231 |
Exchange – Traded Funds | $ 112,220,990 | $ — | $ — | $ 112,220,990 |
Money Market Fund | 4,186,792 | — | — | 4,186,792 |
Total | $1,527,133,013 | $ — | $ — | $1,527,133,013 |
See accompanying Notes to Financial Statements.
15
Table of Contents
Schedule of Investments ARK Fintech Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 100.1% | | | | | |
Banks – 1.9% | | | | | |
NU Holdings Ltd., Class A (Brazil)* | | 2,275,150 | | $ | 19,589,041 |
Broadline Retail – 8.0% | | | | | |
Global-e Online Ltd. (Israel)* | | 1,076,080 | | | 40,643,542 |
MercadoLibre, Inc. (Brazil)* | | 24,199 | | | 41,424,090 |
Total Broadline Retail | | | | | 82,067,632 |
Capital Markets – 16.4% | | | | | |
Coinbase Global, Inc., Class A* | | 899,835 | | | 115,358,847 |
Intercontinental Exchange, Inc. | | 66,176 | | | 8,426,190 |
Robinhood Markets, Inc., Class A* | | 4,178,755 | | | 44,879,829 |
Total Capital Markets | | | | | 168,664,866 |
Consumer Finance – 3.4% | | | | | |
Kaspi.KZ JSC (Kazakhstan)(a) | | 162,799 | | | 14,977,508 |
SoFi Technologies, Inc.* | | 2,505,352 | | | 19,616,906 |
Total Consumer Finance | | | | | 34,594,414 |
Entertainment – 5.0% | | | | | |
ROBLOX Corp., Class A* | | 614,549 | | | 23,850,647 |
Roku, Inc.* | | 313,499 | | | 27,606,722 |
Total Entertainment | | | | | 51,457,369 |
Financial Services – 19.7% | | | | | |
Adyen NV (Netherlands)*(b) | | 38,374 | | | 48,570,379 |
AvidXchange Holdings, Inc.* | | 1,053,909 | | | 11,550,843 |
Block, Inc.* | | 1,262,577 | | | 82,080,131 |
StoneCo Ltd., Class A (Brazil)* | | 1,652,484 | | | 28,406,200 |
Toast, Inc., Class A* | | 1,819,928 | | | 32,340,120 |
Total Financial Services | | | | | 202,947,673 |
Health Care Technology – 1.7% | | | | | |
Teladoc Health, Inc.* | | 901,504 | | | 17,516,223 |
Hotels, Restaurants & Leisure – 6.9% | | | |
DraftKings, Inc., Class A* | | 1,816,644 | | | 70,939,948 |
Insurance – 2.6% | | | | | |
Discovery Ltd. (South Africa) | | 3,544,782 | | | 26,228,263 |
Interactive Media & Services – 4.3% | | | |
LY Corp. (Japan) | | 5,374,814 | | | 16,871,613 |
Meta Platforms, Inc., Class A* | | 15,828 | | | 6,175,136 |
Pinterest, Inc., Class A* | | 563,350 | | | 21,108,725 |
Total Interactive Media & Services | | | | | 44,155,474 |
IT Services – 14.8% | | | | | |
Shopify, Inc., Class A (Canada)* | | 1,234,709 | | | 98,863,150 |
Twilio, Inc., Class A* | | 760,146 | | | 53,461,068 |
Total IT Services | | | | | 152,324,218 |
Investments | | Shares | | Value |
Real Estate Management & Development – 0.5% | |
Zillow Group, Inc., Class C* | | 87,736 | | $ | 4,986,914 | |
Semiconductors & Semiconductor Equipment – 1.2% | |
NVIDIA Corp. | | 20,740 | | | 12,760,700 | |
Software – 13.7% | | | | | | |
BILL Holdings Inc* | | 249,243 | | | 19,453,416 | |
Crowdstrike Holdings, Inc., Class A* | | 26,133 | | | 7,643,902 | |
Intuit, Inc. | | 61,633 | | | 38,910,762 | |
Palantir Technologies, Inc., Class A* | | 794,729 | | | 12,787,190 | |
UiPath, Inc., Class A* | | 2,713,635 | | | 62,359,332 | |
Total Software | | | | | 141,154,602 | |
Total Common Stocks (Cost $1,582,200,987) | | | | | 1,029,387,337 | |
MONEY MARKET FUND – 0.0%(c) | | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(d) (Cost $200,412) | | 200,412 | | | 200,412 | |
Total Investments – 100.1% (Cost $1,582,401,399) | | | | | 1,029,587,749 | |
Liabilities in Excess of Other Assets – (0.1)% | | | (518,605 | ) |
Net Assets – 100.0% | | | | $ | 1,029,069,144 | |
See accompanying Notes to Financial Statements.
16
Table of Contents
Schedule of Investments (continued) ARK Fintech Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Fintech Innovation ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $1,029,387,337 | $ — | $ — | $1,029,387,337 |
Money Market Fund | 200,412 | — | — | 200,412 |
Total | $1,029,587,749 | $ — | $ — | $1,029,587,749 |
See accompanying Notes to Financial Statements.
17
Table of Contents
Schedule of Investments ARK Space Exploration & Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 94.8% | | | | | |
Aerospace & Defense – 36.3% | | | | | |
AeroVironment, Inc.* | | 164,944 | | $ | 19,898,844 |
Airbus SE (France) | | 22,175 | | | 3,541,942 |
Archer Aviation, Inc., Class A* | | 1,942,781 | | | 9,383,632 |
Elbit Systems Ltd. (Israel) | | 20,723 | | | 4,285,516 |
HEICO Corp. | | 18,213 | | | 3,270,873 |
Kratos Defense & Security Solutions, Inc.* | | 1,134,348 | | | 19,204,512 |
L3Harris Technologies, Inc. | | 62,980 | | | 13,126,292 |
Lockheed Martin Corp. | | 6,324 | | | 2,715,589 |
Mynaric AG (Germany)*(a) | | 553,743 | | | 3,045,586 |
Rocket Lab USA, Inc.* | | 1,117,071 | | | 5,417,794 |
Spirit AeroSystems Holdings, Inc., Class A* | | 43,017 | | | 1,181,247 |
Thales SA (France) | | 37,820 | | | 5,532,012 |
Total Aerospace & Defense | | | | | 90,603,839 |
Air Freight & Logistics – 1.1% | | | | | |
JD Logistics, Inc. (China)*(b) | | 3,217,854 | | | 2,798,867 |
Broadline Retail – 3.1% | | | | | |
Amazon.com, Inc.* | | 50,270 | | | 7,801,904 |
Diversified Telecommunication – 7.7% | | | | | |
Iridium Communications, Inc. | | 528,061 | | | 19,147,492 |
Electronic Equipment, Instruments & Components – 9.9% |
Teledyne Technologies, Inc.* | | 7,132 | | | 2,984,528 |
Trimble, Inc.* | | 425,101 | | | 21,620,637 |
Total Electronic Equipment, Instruments & Components | | | | | 24,605,165 |
Household Durables – 2.2% | | | | | |
Garmin Ltd. | | 46,402 | | | 5,544,575 |
Industrial Conglomerates – 1.6% | | | | | |
Honeywell International, Inc. | | 19,504 | | | 3,944,879 |
Interactive Media & Services – 2.1% | | | | | |
Alphabet, Inc., Class C* | | 36,546 | | | 5,182,223 |
Machinery – 9.5% | | | | | |
3D Systems Corp.* | | 289,422 | | | 1,386,331 |
Deere & Co. | | 18,797 | | | 7,398,123 |
Komatsu Ltd. (Japan) | | 421,188 | | | 12,148,003 |
Markforged Holding Corp.* | | 3,005,458 | | | 2,034,996 |
Stratasys Ltd.* | | 790 | | | 10,444 |
Velo3D, Inc.* | | 2,416,618 | | | 757,610 |
Total Machinery | | | | | 23,735,507 |
Passenger Airlines – 4.3% | | | | | |
Blade Air Mobility, Inc.* | | 1,567,803 | | | 4,672,053 |
Joby Aviation, Inc.* | | 1,123,034 | | | 6,131,765 |
Total Passenger Airlines | | | | | 10,803,818 |
Investments | | Shares | | Value |
Semiconductors & Semiconductor Equipment – 4.2% |
Teradyne, Inc. | | 108,219 | | $ | 10,452,873 |
Software – 12.8% | | | | | |
ANSYS, Inc.* | | 10,412 | | | 3,413,366 |
Dassault Systemes SE (France) | | 190,426 | | | 9,926,402 |
Synopsys, Inc.* | | 7,374 | | | 3,932,923 |
UiPath, Inc., Class A* | | 462,862 | | | 10,636,569 |
Unity Software, Inc.* | | 126,127 | | | 4,086,515 |
Total Software | | | | | 31,995,775 |
Total Common Stocks (Cost $337,370,890) | | | | | 236,616,917 |
EXCHANGE-TRADED FUND – 5.0% | | | | | |
Equity Fund – 5.0% | | | | | |
The 3D Printing ETF*† (Cost $22,338,704) | | 568,963 | | | 12,477,359 |
MONEY MARKET FUND – 0.2% | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund 5.21%(c) (Cost $568,594) | | 568,594 | | | 568,594 |
Total Investments – 100.0% (Cost $360,278,188) | | | | | 249,662,870 |
Other Assets in Excess of Liabilities – 0.0%(d) | | | 2,266 |
Net Assets – 100.0% | | | | $ | 249,665,136 |
See accompanying Notes to Financial Statements.
18
Table of Contents
Schedule of Investments (continued) ARK Space Exploration & Innovation ETF | | |
January 31, 2024 (Unaudited) | | |
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2023 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 1/31/2024 | Value ($) at 1/31/2024 |
Exchange-Traded Fund — 5.0% | | | | | | | | |
Equity Fund — 5.0% | | | | | | | | |
The 3D Printing ETF 16,332,566 | — | (2,095,286) | (1,896,649) | 136,728 | — | — | 568,963 | 12,477,359 |
$16,332,566 | $ — | $(2,095,286) | $(1,896,649) | $136,728 | $ — | $ — | 568,963 | $12,477,359 |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Space Exploration & Innovation ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $236,616,917 | $ — | $ — | $236,616,917 |
Exchange – Traded Fund | 12,477,359 | — | — | 12,477,359 |
Money Market Fund | 568,594 | — | — | 568,594 |
Total | $249,662,870 | $ — | $ — | $249,662,870 |
See accompanying Notes to Financial Statements.
19
Table of Contents
Schedule of Investments The 3D Printing ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 99.7% | | | | | |
Aerospace & Defense – 3.3% | | | | | |
Hexcel Corp. | | 2,052 | | $ | 136,232 |
L3Harris Technologies, Inc. | | 10,860 | | | 2,263,441 |
Moog, Inc., Class A | | 15,891 | | | 2,221,562 |
Total Aerospace & Defense | | | | | 4,621,235 |
Air Freight & Logistics – 1.4% | | | | | |
United Parcel Service, Inc., Class B | | 14,274 | | | 2,025,481 |
Automobile Components – 1.6% | | | | | |
Cie Generale des Etablissements Michelin SCA (France) | | 66,892 | | | 2,227,974 |
Chemicals – 0.8% | | | | | |
5N Plus, Inc. (Canada)* | | 54,896 | | | 149,443 |
Arkema SA (France) | | 1,404 | | | 153,702 |
Avient Corp. | | 4,165 | | | 150,815 |
Koninklijke DSM NV (Netherlands) | | 1,409 | | | 149,346 |
DuPont de Nemours, Inc. | | 2,069 | | | 127,864 |
Eastman Chemical Co. | | 1,745 | | | 145,795 |
Evonik Industries AG (Germany) | | 8,143 | | | 150,878 |
Toray Industries, Inc. (Japan) | | 31,188 | | | 156,915 |
Total Chemicals | | | | | 1,184,758 |
Electrical Equipment – 1.7% | | | | | |
AMETEK, Inc. | | 14,191 | | | 2,299,651 |
SGL Carbon SE (Germany)* | | 23,584 | | | 149,992 |
Total Electrical Equipment | | | | | 2,449,643 |
Electronic Equipment, Instruments & Components – 9.6% |
FARO Technologies, Inc.* | | 254,778 | | | 5,768,174 |
Hexagon AB, Class B (Sweden) | | 214,304 | | | 2,347,600 |
Jabil, Inc. | | 1,171 | | | 146,715 |
Renishaw PLC (United Kingdom) | | 120,041 | | | 5,330,558 |
Total Electronic Equipment, Instruments & Components | | | | | 13,593,047 |
Health Care Equipment & Supplies – 9.1% | | | |
Align Technology, Inc.* | | 8,656 | | | 2,313,922 |
DENTSPLY SIRONA, Inc. | | 147,295 | | | 5,118,501 |
Straumann Holding AG (Switzerland) | | 35,723 | | | 5,480,880 |
Total Health Care Equipment & Supplies | | | | | 12,913,303 |
Household Durables – 4.0% | | | | | |
Nikon Corp. (Japan) | | 541,404 | | | 5,582,148 |
Investments | | Shares | | Value |
Industrial Conglomerates – 5.5% | | | | | |
3M Co. | | 1,426 | | $ | 134,543 |
General Electric Co. | | 17,489 | | | 2,315,893 |
Siemens AG (Germany) | | 29,858 | | | 5,378,332 |
Total Industrial Conglomerates | | | | | 7,828,768 |
Life Sciences Tools & Services – 4.8% | | | | | |
BICO Group AB (Sweden)* | | 1,169,293 | | | 6,707,902 |
Machinery – 21.7% | | | | | |
3D Systems Corp.* | | 1,102,689 | | | 5,281,880 |
Desktop Metal, Inc., Class A* | | 7,824,332 | | | 5,075,644 |
Kennametal, Inc. | | 6,231 | | | 152,784 |
Lincoln Electric Holdings, Inc. | | 10,369 | | | 2,304,199 |
Markforged Holding Corp.* | | 5,914,670 | | | 4,004,823 |
OC Oerlikon Corp. AG (Switzerland) | | 561,719 | | | 2,457,907 |
Proto Labs, Inc.* | | 148,074 | | | 5,343,991 |
Sandvik AB (Sweden) | | 7,685 | | | 162,021 |
Stratasys Ltd.* | | 397,309 | | | 5,252,425 |
Velo3D, Inc.* | | 2,054,556 | | | 644,103 |
Total Machinery | | | | | 30,679,777 |
Metals & Mining – 2.0% | | | | | |
ATI Inc.* | | 3,565 | | | 145,702 |
Carpenter Technology Corp. | | 2,302 | | | 141,780 |
Kaiser Aluminum Corp. | | 36,691 | | | 2,381,246 |
voestalpine AG (Austria) | | 5,157 | | | 153,819 |
Total Metals & Mining | | | | | 2,822,547 |
Software – 22.2% | | | | | |
Altair Engineering, Inc., Class A* | | 60,571 | | | 5,149,746 |
ANSYS, Inc.* | | 15,468 | | | 5,070,874 |
Autodesk, Inc.* | | 21,091 | | | 5,353,107 |
Dassault Systemes SE (France) | | 104,137 | | | 5,428,386 |
Materialise NV (Belgium)*(a) | | 888,611 | | | 5,038,424 |
PTC, Inc.* | | 29,784 | | | 5,380,480 |
Total Software | | | | | 31,421,017 |
Technology Hardware, Storage & Peripherals – 8.2% |
Eastman Kodak Co.* | | 44,754 | | | 154,401 |
HP, Inc. | | 185,170 | | | 5,316,231 |
Nano Dimension Ltd. (Israel)*(a) | | 2,445,106 | | | 5,868,255 |
Xerox Holdings Corp. | | 9,503 | | | 175,425 |
Total Technology Hardware, Storage & Peripherals | | | | | 11,514,312 |
See accompanying Notes to Financial Statements.
20
Table of Contents
Schedule of Investments (continued) The 3D Printing ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
Trading Companies & Distributors – 3.8% | | | |
Xometry, Inc., Class A* | | 164,344 | | $ | 5,288,590 |
Total Common Stocks (Cost $199,948,851) | | | | | 140,860,502 |
PREFERRED STOCK – 0.1% | | | | | |
Household Products – 0.1% | | | | | |
Henkel AG & Co. KGaA (Germany) (Cost $199,584) | | 1,884 | | | 144,762 |
MONEY MARKET FUND – 0.1% | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(b) (Cost $139,810) | | 139,810 | | | 139,810 |
Total Investments – 99.9% (Cost $200,288,245) | | | | | 141,145,074 |
Other Assets in Excess of Liabilities – 0.1% | | | | | 188,057 |
Net Assets – 100.0% | | | | $ | 141,333,131 |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
The 3D Printing ETF | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | |
Common Stocks‡ | $141,009,848 | $149,346 | $ — | $140,860,502 |
Preferred Stock‡ | 144,762 | — | — | 144,762 |
Money Market Fund | 139,810 | — | — | 139,810 |
Total | $140,995,728 | $149,346 | $ — | $141,145,074 |
See accompanying Notes to Financial Statements.
21
Table of Contents
Schedule of Investments ARK Israel Innovative Technology ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
COMMON STOCKS – 99.8% | | | | | |
Aerospace & Defense – 2.1% | | | | | |
Elbit Systems Ltd. (Israel) | | 10,847 | | $ | 2,239,131 |
Automobile Components – 1.9% | | | | | |
Mobileye Global, Inc., Class A (Israel)* | | 79,545 | | | 2,057,034 |
Biotechnology – 2.3% | | | | | |
Gamida Cell Ltd. (Israel)* | | 1,554 | | | 598 |
UroGen Pharma Ltd.* | | 153,371 | | | 2,407,925 |
Total Biotechnology | | | | | 2,408,523 |
Communications Equipment – 6.3% | | | | | |
AudioCodes Ltd. (Israel) | | 193,483 | | | 2,165,075 |
Ceragon Networks Ltd. (Israel)* | | 2,196 | | | 5,402 |
Gilat Satellite Networks Ltd. (Israel)* | | 376,027 | | | 2,380,251 |
Ituran Location and Control Ltd. (Israel) | | 86,883 | | | 2,161,649 |
Total Communications Equipment | | | | | 6,712,377 |
Diversified Telecommunication – 2.2% | | | | | |
Bezeq The Israeli Telecommunication Corp. Ltd. (Israel) | | 1,732,139 | | | 2,297,331 |
Electronic Equipment, Instruments & Components – 4.4% |
Nayax Ltd. (Israel)* | | 100,334 | | | 2,460,662 |
Telsys Ltd. (Israel) | | 33,310 | | | 2,172,421 |
Total Electronic Equipment, Instruments & Components | | | | | 4,633,083 |
Entertainment – 2.1% | | | | | |
Playtika Holding Corp.* | | 305,886 | | | 2,208,497 |
Health Care Equipment & Supplies – 4.1% |
Inmode Ltd.* | | 96,986 | | | 2,297,599 |
Nano-X Imaging Ltd. (Israel)* | | 385,255 | | | 2,095,787 |
Total Health Care Equipment & Supplies | | | | | 4,393,386 |
Hotels, Restaurants & Leisure – 4.2% |
Fattal Holdings 1998 Ltd. (Israel)* | | 20,135 | | | 2,293,494 |
NEOGAMES SA (Israel)* | | 78,905 | | | 2,207,762 |
Total Hotels, Restaurants & Leisure | | | | | 4,501,256 |
Interactive Media & Services – 2.4% | | | | | |
Taboola.com Ltd. (Israel)* | | 552,763 | | | 2,609,041 |
IT Services – 6.4% | | | | | |
Matrix IT Ltd. (Israel) | | 119,969 | | | 2,266,017 |
One Software Technologies Ltd. (Israel) | | 180,582 | | | 2,274,757 |
Wix.com Ltd. (Israel)* | | 18,022 | | | 2,286,631 |
Total IT Services | | | | | 6,827,405 |
Life Sciences Tools & Services – 2.6% | | | | | |
Compugen Ltd. (Israel)* | | 1,089,358 | | | 2,806,006 |
Machinery – 2.1% | | | | | |
Stratasys Ltd.* | | 167,247 | | | 2,211,005 |
Media – 2.2% | | | | | |
Perion Network Ltd. (Israel)* | | 78,349 | | | 2,307,378 |
Investments | | Shares | | Value |
Personal Care Products – 2.0% | | | | | |
Oddity Tech Ltd., Class A (Israel)* | | 51,778 | | $ | 2,138,431 |
Pharmaceuticals – 4.4% | | | | | |
Taro Pharmaceutical Industries Ltd.* | | 52,873 | | | 2,276,183 |
Teva Pharmaceutical Industries Ltd. (Israel)*(a) | | 201,386 | | | 2,436,771 |
Total Pharmaceuticals | | | | | 4,712,954 |
Professional Services – 6.7% | | | | | |
Danel Adir Yeoshua Ltd. (Israel) | | 25,637 | | | 2,221,604 |
Fiverr International Ltd.* | | 90,401 | | | 2,433,595 |
Hilan Ltd. (Israel) | | 43,931 | | | 2,449,610 |
Total Professional Services | | | | | 7,104,809 |
Semiconductors & Semiconductor Equipment – 6.4% |
Camtek Ltd. (Israel)* | | 29,243 | | | 2,276,275 |
Nova Ltd. (Israel)* | | 16,213 | | | 2,347,804 |
Tower Semiconductor Ltd. (Israel)* | | 76,966 | | | 2,220,469 |
Valens Semiconductor Ltd. (Israel)* | | 3,224 | | | 7,480 |
Total Semiconductors & Semiconductor Equipment | | | | | 6,852,028 |
Software – 30.7% | | | | | |
Cellebrite DI Ltd. (Japan)* | | 269,900 | | | 2,439,896 |
Check Point Software Technologies Ltd. (Israel)* | | 14,068 | | | 2,235,827 |
Cognyte Software Ltd. (Israel)* | | 382,979 | | | 2,711,491 |
CyberArk Software Ltd.* | | 9,782 | | | 2,283,901 |
JFrog Ltd. (Israel)* | | 67,288 | | | 2,188,879 |
Magic Software Enterprises Ltd. (Israel) | | 205,901 | | | 2,090,761 |
Monday.com Ltd.* | | 11,622 | | | 2,441,085 |
Nice Ltd. (Israel)*(a) | | 10,851 | | | 2,258,093 |
Pagaya Technologies Ltd., Class A* | | 2,048,596 | | | 2,396,857 |
Radware Ltd. (Israel)* | | 130,854 | | | 2,392,011 |
Riskified Ltd., Class A* | | 510,641 | | | 2,343,843 |
Sapiens International Corp. NV (Israel) | | 81,976 | | | 2,237,945 |
SimilarWeb Ltd. (Israel)* | | 402,737 | | | 2,505,024 |
WalkMe Ltd. (Israel)* | | 210,150 | | | 2,164,545 |
Total Software | | | | | 32,690,158 |
Wireless Telecommunication Services – 4.3% |
Cellcom Israel Ltd. (Israel)* | | 553,029 | | | 2,274,124 |
Partner Communications Co. Ltd. (Israel)* | | 487,666 | | | 2,259,353 |
Total Wireless Telecommunication Services | | | | | 4,533,477 |
Total Common Stocks (Cost $107,208,395) | | | | | 106,243,310 |
See accompanying Notes to Financial Statements.
22
Table of Contents
Schedule of Investments (concluded) ARK Israel Innovative Technology ETF | | |
January 31, 2024 (Unaudited) | | |
Investments | | Shares | | Value |
MONEY MARKET FUND – 0.2% | |
Goldman Sachs Financial Square Treasury Obligations Fund, 5.21%(b) (Cost $285,385) | | 285,385 | | $ | 285,385 | |
Total Investments – 100.0% (Cost $107,493,780) | | | | | 106,528,695 | |
Liabilities in Excess of Other Assets – (0.0)%(c) | | | | | (42,531 | ) |
Net Assets – 100.0% | | | | $ | 106,486,164 | |
Country | Value | % of Net Assets |
Israel | $ 80,502,924 | 75.6% |
Japan | 2,439,896 | 2.3 |
United States | 23,585,875 | 22.1 |
Total Investments | 106,528,695 | 100.0 |
Liabilities in Excess of Other Assets | (42,531) | (0.0)(c) |
Net Assets | $106,486,164 | 100.0% |
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 – Quoted prices in active markets for identical assets.
• Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of January 31, 2024, based upon the three levels defined above:
ARK Israel Innovative Technology ETF | | Level 1 | | Level 2 | | Level 3 | | Total |
Assets |
Common Stocks‡ | | $106,243,310 | | $ — | | $ — | | $106,243,310 |
Money Market Fund | | 285,385 | | — | | — | | 285,385 |
Total | | $106,528,695 | | $ — | | $ — | | $106,528,695 |
See accompanying Notes to Financial Statements.
23
Table of Contents
Statements of Assets and Liabilities | | |
January 31, 2024 (Unaudited) | | |
| | ARK Genomic Revolution ETF | | ARK Autonomous Technology & Robotics ETF | | ARK Innovation ETF | | ARK Next Generation Internet ETF | |
ASSETS: | | | | | | | | | |
Investments in non-affiliated securities at fair value (Note 2) | | $ 1,333,691,476 | | $ 907,572,851 | | $ 5,112,646,683 | | $ 1,400,098,462 | |
Investments in affiliated securities at fair value (Note 2) | | 317,888,085 | | 21,823,316 | | 2,402,712,221 | | 127,034,551 | |
Receivables: | | | | | | | | | |
Dividends and interest | | 68,421 | | 226,593 | | 49,431 | | 4,530 | |
Capital shares sold | | — | | — | | 18,750,595 | | — | |
Investment securities sold | | 59,040,280 | | 7,558,269 | | 167,126,025 | | 9,160,890 | |
Tax reclaims | | 5,173,433 | | 44,776 | | 1,778,642 | | — | |
Total Assets | | 1,715,861,695 | | 937,225,805 | | 7,703,063,597 | | 1,536,298,433 | |
LIABILITIES: | | | | | | | | | |
Payables: | | | | | | | | | |
Capital shares purchased | | 59,250,693 | | 5,248,614 | | 137,323,203 | | 7,052,099 | |
Investment securities purchased | | 338,016 | | 2,341,638 | | 56,242,525 | | 5,192,388 | |
Management fees (Note 3) | | 1,265,276 | | 626,011 | | 5,249,748 | | 1,018,308 | |
Total Liabilities | | 60,853,985 | | 8,216,263 | | 198,815,476 | | 13,262,795 | |
NET ASSETS | | $ 1,655,007,710 | | $ 929,009,542 | | $ 7,504,248,121 | | $ 1,523,035,638 | |
NET ASSETS CONSIST OF: | | | | | | | | | |
Paid-in capital | | $ 6,859,014,209 | | $1,766,653,889 | | $ 20,925,809,439 | | $ 3,923,586,796 | |
Total accumulated loss | | (5,204,006,499) | | (837,644,347) | | (13,421,561,318) | | (2,400,551,158 | ) |
NET ASSETS | | $ 1,655,007,710 | | $ 929,009,542 | | $ 7,504,248,121 | | $ 1,523,035,638 | |
Shares outstanding no par value (unlimited shares authorized) | | 58,100,000 | | 17,700,000 | | 165,150,000 | | 21,900,000 | |
Net asset value, per share | | $ 28.49 | | $ 52.49 | | $ 45.44 | | $ 69.55 | |
Investments in non-affiliated securities at cost | | $ 3,692,561,679 | | $1,272,281,757 | | $ 8,963,064,426 | | $ 2,492,609,606 | |
Investments in affiliated securities at cost | | $ 1,635,980,515 | | $ 155,236,853 | | $ 7,554,814,653 | | $ 215,933,845 | |
See accompanying Notes to Financial Statements.
24
Table of Contents
Statements of Assets and Liabilities (concluded)
| | |
January 31, 2024 (Unaudited) | | |
| | ARK Fintech Innovation ETF | | ARK Space Exploration & Innovation ETF | | The 3D Printing ETF | | ARK Israel Innovative Technology ETF | |
ASSETS: | | | | | | | | | |
Investments in non-affiliated securities at fair value (Note 2) | | $ 1,029,587,749 | | $ 237,185,511 | | $ 141,145,074 | | $ 106,528,695 | |
Investments in affiliated securities at fair value (Note 2) | | — | | 12,477,359 | | — | | — | |
Cash | | — | | — | | 594,464 | | 351,331 | |
Receivables: | | | | | | | | | |
Dividends and interest | | 3,396 | | 30,541 | | 29,901 | | 588 | |
Investment securities sold | | 5,349,096 | | 644,301 | | — | | — | |
Tax reclaims | | 17,779 | | 118,626 | | 248,762 | | — | |
Total Assets | | 1,034,958,020 | | 250,456,338 | | 142,018,201 | | 106,880,614 | |
LIABILITIES: | | | | | | | | | |
Due to custodian for foreign currency | | 7,785 | | 4,090 | | 9,863 | | 860 | |
Due to Broker | | — | | — | | — | | 544 | |
Payables: | | | | | | | | | |
Investment securities purchased | | 5,201,926 | | 629,960 | | 594,464 | | 351,331 | |
Management fees (Note 3) | | 679,165 | | 157,152 | | 79,512 | | 40,857 | |
Other accrued expenses | | — | | — | | 1,231 | | 858 | |
Total Liabilities | | 5,888,876 | | 791,202 | | 685,070 | | 394,450 | |
NET ASSETS | | $ 1,029,069,144 | | $ 249,665,136 | | $ 141,333,131 | | $ 106,486,164 | |
NET ASSETS CONSIST OF: | | | | | | | | | |
Paid-in capital | | $ 2,751,960,601 | | $ 411,444,078 | | $ 389,906,900 | | $ 234,849,538 | |
Total accumulated loss | | (1,722,891,457) | | (161,778,942) | | (248,573,769) | | (128,363,374 | ) |
NET ASSETS | | $ 1,029,069,144 | | $ 249,665,136 | | $ 141,333,131 | | $ 106,486,164 | |
Shares outstanding no par value (unlimited shares authorized) | | 40,250,000 | | 17,500,000 | | 6,400,000 | | 5,450,000 | |
Net asset value, per share | | $ 25.57 | | $ 14.27 | | $ 22.08 | | $ 19.54 | |
Investments in non-affiliated securities at cost | | $ 1,582,401,399 | | $ 337,939,484 | | $ 200,288,245 | | $ 107,493,780 | |
Investments in affiliated securities at cost | | $ — | | $ 22,338,704 | | $ — | | $ — | |
See accompanying Notes to Financial Statements.
25
Table of Contents
Statements of Operations | | |
For the Six Months Ended January 31, 2024 (Unaudited) | | |
| ARK Genomic Revolution ETF | | ARK Autonomous Technology & Robotics ETF | | ARK Innovation ETF | | ARK Next Generation Internet ETF | |
INVESTMENT INCOME: | | | | | | | | |
Unaffiliated dividend income | $ 325,398 | | $ 2,445,378 | | $ 361,031 | | $ 122,607 | |
Affiliated dividend income | — | | — | | — | | 3,437 | |
Foreign withholding tax | — | | (216,844) | | — | | (9,011 | ) |
Total Income | 325,398 | | 2,228,534 | | 361,031 | | 117,033 | |
EXPENSES: | | | | | | | | |
Management fees (Note 3) | 7,003,942 | | 3,789,384 | | 29,067,315 | | 5,409,753 | |
Overdraft expense | 248 | | — | | 1,770 | | 11 | |
Total Expenses | 7,004,190 | | 3,789,384 | | 29,069,085 | | 5,409,764 | |
Net Investment Loss | (6,678,792) | | (1,560,850) | | (28,708,054) | | (5,292,731 | ) |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | |
Investments in non-affiliated securities | (285,201,847) | | (68,663,784) | | (621,382,776) | | (402,734,110 | ) |
Investments in affiliated securities | (85,835,533) | | — | | (765,970,980) | | (3,934,575 | ) |
In-kind redemptions – non-affiliated securities | 26,547,101 | | 20,225,309 | | 444,569,791 | | 50,406,838 | |
In-kind redemptions – affiliated securities | (6,415,983) | | (1,992,422) | | 116,647,772 | | (2,278,426 | ) |
Net realized loss | (350,906,262) | | (50,430,897) | | (826,136,193) | | (358,540,273 | ) |
Change in unrealized appreciation (depreciation) on: | | | | | | | | |
Investments in non-affiliated securities | (479,434,831) | | (52,997,492) | | (511,544,072) | | 437,177,091 | |
Investments in affiliated securities | 212,050,242 | | (21,252,593) | | 458,113,212 | | (44,857,147 | ) |
Change in unrealized appreciation (depreciation) | (267,384,589) | | (74,250,085) | | (53,430,860) | | 392,319,944 | |
Net realized and unrealized gain (loss) on investments and foreign currency translation | (618,290,851) | | (124,680,982) | | (879,567,053) | | 33,779,671 | |
Net Increase (Decrease) in Net Assets Resulting From Operations | $(624,969,643) | | $(126,241,832) | | $(908,275,107) | | $ 28,486,940 | |
See accompanying Notes to Financial Statements.
26
Table of Contents
Statements of Operations (concluded)
| | |
For the Six Months Ended January 31, 2024 (Unaudited) | | |
| | ARK Fintech Innovation ETF | | ARK Space Exploration & Innovation ETF | | The 3D Printing ETF | | ARK Israel Innovative Technology ETF | |
INVESTMENT INCOME: | | | | | | | | | |
Unaffiliated dividend income | | $ 1,029,362 | | $ 803,457 | | $ 568,510 | | $ 229,433 | |
Foreign withholding tax | | (34,139) | | (31,145) | | (16,782) | | (56,147 | ) |
Total Income | | 995,223 | | 772,312 | | 551,728 | | 173,286 | |
EXPENSES: | | | | | | | | | |
Management fees (Note 3) | | 3,536,587 | | 990,192 | | 487,332 | | 222,929 | |
Overdraft expense | | 1,087 | | 154 | | 467 | | 345 | |
Other expenses | | — | | — | | 7,479 | | 4,644 | |
Total Expenses | | 3,537,674 | | 990,346 | | 495,278 | | 227,918 | |
Less expense waivers and reimbursements | | — | | (42,125)(1) | | — | | — | |
Net Expenses | | 3,537,674 | | 948,221 | | 495,278 | | 227,918 | |
Net Investment Income (Loss) | | (2,542,451) | | (175,909) | | 56,450 | | (54,632 | ) |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | | |
Investments in non-affiliated securities | | (108,738,925) | | (14,849,431) | | (13,646,410) | | (9,570,181 | ) |
Investments in affiliated securities | | — | | (898,095) | | — | | — | |
Foreign currency transactions | | 26,690 | | (4,231) | | (3,662) | | (14,119 | ) |
In-kind redemptions – non-affiliated securities | | 28,287,731 | | 754,850 | | 2,060,628 | | 2,490,118 | |
In-kind redemptions – affiliated securities | | — | | (998,554) | | — | | — | |
Net realized loss | | (80,424,504) | | (15,995,461) | | (11,589,444) | | (7,094,182 | ) |
Change in unrealized appreciation (depreciation) on: | | | | | | | | | |
Investments in non-affiliated securities | | 122,117,998 | | (9,128,949) | | (7,047,927) | | 4,022,893 | |
Investments in affiliated securities | | — | | 136,728 | | — | | — | |
Foreign currency translation | | (696) | | 1,916 | | 1,050 | | (15 | ) |
Change in unrealized appreciation (depreciation) | | 122,117,302 | | (8,990,305) | | (7,046,877) | | 4,022,878 | |
Net realized and unrealized gain (loss) on investments and foreign currency translation | | 41,692,798 | | (24,985,766) | | (18,636,321) | | (3,071,304 | ) |
Net Increase (Decrease) in Net Assets Resulting From Operations | | $ 39,150,347 | | $(25,161,675) | | $ (18,579,871) | | $(3,125,936 | ) |
(1) See Notes to Financial Statements (Note 3).
See accompanying Notes to Financial Statements.
27
Table of Contents
Statements of Changes in Net Assets | | |
| | |
| | ARK Genomic Revolution ETF | | ARK Autonomous Technology & Robotics ETF | |
| | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | |
OPERATIONS: | | | | | | | | | |
Net investment loss | | $ (6,678,792) | | $ (15,689,972) | | $ (1,560,850) | | $ (3,125,835 | ) |
Net realized loss on investments and foreign currency transactions | | (350,906,262) | | (853,818,426) | | (50,430,897) | | (277,949,443 | ) |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | (267,384,589) | | 884,732,526 | | (74,250,085) | | 309,108,305 | |
Net increase (decrease) in net assets resulting from operations | | (624,969,643) | | 15,224,128 | | (126,241,832) | | 28,033,027 | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | |
Distributions from distributable earnings | | — | | — | | — | | — | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | |
Proceeds from shares sold | | 517,693,099 | | 1,362,712,302 | | 2,920,797 | | 69,227,641 | |
Cost of shares redeemed | | (734,377,345) | | (1,661,300,555) | | (118,327,147) | | (138,541,694 | ) |
Net decrease in net assets resulting from shareholder transactions | | (216,684,246) | | (298,588,253) | | (115,406,350) | | (69,314,053 | ) |
Decrease in net assets | | (841,653,889) | | (283,364,125) | | (241,648,182) | | (41,281,026 | ) |
NET ASSETS: | | | | | | | | | |
Beginning of period | | 2,496,661,599 | | 2,780,025,724 | | 1,170,657,724 | | 1,211,938,750 | |
End of period | | $1,655,007,710 | | $ 2,496,661,599 | | $ 929,009,542 | | $1,170,657,724 | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | |
Shares outstanding, beginning of period | | 65,800,000 | | 75,805,000 | | 19,900,000 | | 21,600,000 | |
Shares sold | | 17,150,000 | | 41,200,000 | | 50,000 | | 1,300,000 | |
Shares redeemed | | (24,850,000) | | (51,205,000) | | (2,250,000) | | (3,000,000 | ) |
Shares outstanding, end of period | | 58,100,000 | | 65,800,000 | | 17,700,000 | | 19,900,000 | |
See accompanying Notes to Financial Statements.
28
Table of Contents
Statements of Changes in Net Assets (continued)
| | |
| | |
| | ARK Innovation ETF | | ARK Next Generation Internet ETF | |
| | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | |
OPERATIONS: | | | | | | | | | |
Net investment loss | | $ (28,708,054) | | $ (56,870,224) | | $ (5,292,731) | | $ (9,318,781 | ) |
Net realized loss on investments and foreign currency transactions | | (826,136,193) | | (2,067,804,437) | | (358,540,273) | | (468,661,159 | ) |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | (53,430,860) | | 3,013,683,487 | | 392,319,944 | | 758,506,498 | |
Net increase (decrease) in net assets resulting from operations | | (908,275,107) | | 889,008,826 | | 28,486,940 | | 280,526,558 | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | |
Distributions from distributable earnings | | — | | — | | — | | — | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | |
Proceeds from shares sold | | 4,772,315,219 | | 9,791,568,164 | | 176,461,947 | | 376,471,902 | |
Cost of shares redeemed | | (5,655,144,791) | | (10,722,043,209) | | (332,424,210) | | (462,986,678 | ) |
Net decrease in net assets resulting from shareholder transactions | | (882,829,572) | | (930,475,045) | | (155,962,263) | | (86,514,776 | ) |
Increase (decrease) in net assets | | (1,791,104,679) | | (41,466,219) | | (127,475,323) | | 194,011,782 | |
NET ASSETS: | | | | | | | | | |
Beginning of period | | 9,295,352,800 | | 9,336,819,019 | | 1,650,510,961 | | 1,456,499,179 | |
End of period | | $ 7,504,248,121 | | $ 9,295,352,800 | | $1,523,035,638 | | $1,650,510,961 | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | |
Shares outstanding, beginning of period | | 184,350,000 | | 206,850,000 | | 24,550,000 | | 26,700,000 | |
Shares sold | | 108,000,000 | | 245,750,000 | | 2,450,000 | | 7,600,000 | |
Shares redeemed | | (127,200,000) | | (268,250,000) | | (5,100,000) | | (9,750,000 | ) |
Shares outstanding, end of period | | 165,150,000 | | 184,350,000 | | 21,900,000 | | 24,550,000 | |
See accompanying Notes to Financial Statements.
29
Table of Contents
Statements of Changes in Net Assets (continued) | | |
| | |
| | ARK Fintech Innovation ETF | | ARK Space Exploration & Innovation ETF | |
| | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | |
OPERATIONS: | | | | | | | | | |
Net investment loss | | $ (2,542,451) | | $ (4,720,822) | | $ (175,909) | | $ (287,594 | ) |
Net realized loss on investments and foreign currency transactions | | (80,424,504) | | (397,541,775) | | (15,995,461) | | (8,877,064 | ) |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | 122,117,302 | | 663,871,900 | | (8,990,305) | | 18,584,402 | |
Net increase (decrease) in net assets resulting from operations | | 39,150,347 | | 261,609,303 | | (25,161,675) | | 9,419,744 | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | |
Distributions from distributable earnings | | — | | — | | — | | — | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | |
Proceeds from shares sold | | 30,734,178 | | 152,224,444 | | — | | 5,571,035 | |
Cost of shares redeemed | | (129,104,799) | | (261,975,876) | | (24,111,685) | | (35,588,100 | ) |
Net decrease in net assets resulting from shareholder transactions | | (98,370,621) | | (109,751,432) | | (24,111,685) | | (30,017,065 | ) |
Increase (decrease) in net assets | | (59,220,274) | | 151,857,871 | | (49,273,360) | | (20,597,321 | ) |
NET ASSETS: | | | | | | | | | |
Beginning of period | | 1,088,289,418 | | 936,431,547 | | 298,938,496 | | 319,535,817 | |
End of period | | $1,029,069,144 | | $1,088,289,418 | | $249,665,136 | | $298,938,496 | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | |
Shares outstanding, beginning of period | | 45,050,000 | | 52,300,001 | | 19,200,000 | | 21,400,001 | |
Shares sold | | 1,150,000 | | 8,050,000 | | — | | 450,000 | |
Shares redeemed | | (5,950,000) | | (15,300,001) | | (1,700,000) | | (2,650,001 | ) |
Shares outstanding, end of period | | 40,250,000 | | 45,050,000 | | 17,500,000 | | 19,200,000 | |
See accompanying Notes to Financial Statements.
30
Table of Contents
Statements of Changes in Net Assets (concluded) | | |
| | |
| | The 3D Printing ETF | | ARK Israel Innovative Technology ETF | |
| | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | | Six Months Ended January 31, 2024 (Unaudited) | | Year Ended July 31, 2023 | |
OPERATIONS: | | | | | | | | | |
Net investment income (loss) | | $ 56,450 | | $ (10,814) | | $ (54,632) | | $ (16,504 | ) |
Net realized loss on investments and foreign currency transactions | | (11,589,444) | | (61,642,381) | | (7,094,182) | | (34,260,183 | ) |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | (7,046,877) | | 69,897,846 | | 4,022,878 | | 37,194,723 | |
Net increase (decrease) in net assets resulting from operations | | (18,579,871) | | 8,244,651 | | (3,125,936) | | 2,918,036 | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | |
Distributions from distributable earnings | | — | | — | | — | | — | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | |
Proceeds from shares sold | | — | | 3,488,712 | | 26,827,932 | | 8,621,228 | |
Cost of shares redeemed | | (25,941,949) | | (35,428,704) | | (17,149,862) | | (29,739,323 | ) |
Net increase (decrease) in net assets resulting from shareholder transactions | | (25,941,949) | | (31,939,992) | | 9,678,070 | | (21,118,095 | ) |
Increase (decrease) in net assets | | (44,521,820) | | (23,695,341) | | 6,552,134 | | (18,200,059 | ) |
NET ASSETS: | | | | | | | | | |
Beginning of period | | 185,854,951 | | 209,550,292 | | 99,934,030 | | 118,134,089 | |
End of period | | $141,333,131 | | $185,854,951 | | $106,486,164 | | $ 99,934,030 | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | |
Shares outstanding, beginning of period | | 7,600,000 | | 9,050,001 | | 4,975,000 | | 6,100,001 | |
Shares sold | | — | | 150,000 | | 1,450,000 | | 450,000 | |
Shares redeemed | | (1,200,000) | | (1,600,001) | | (975,000) | | (1,575,001 | ) |
Shares outstanding, end of period | | 6,400,000 | | 7,600,000 | | 5,450,000 | | 4,975,000 | |
See accompanying Notes to Financial Statements.
31
Table of Contents
Financial Highlights ARK Genomic Revolution ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 37.94 | $ 36.67 | $ 84.40 | $ 53.70 | $ 34.50 | $ 29.36 |
Net investment loss(1) | (0.11) | (0.23) | (0.35) | (0.24) | (0.28) | (0.19) |
Net realized and unrealized gain (loss) on investments | (9.34) | 1.50 | (47.00) | 31.73 | 20.53 | 5.80 |
Total gain (loss) from investment operations | (9.45) | 1.27 | (47.35) | 31.49 | 20.25 | 5.61 |
Distributions to shareholders: | | | | | | |
Net realized gains | — | — | (0.38) | (0.79) | (1.05) | (0.47) |
Total distributions | — | — | (0.38) | (0.79) | (1.05) | (0.47) |
Net asset value, end of period | $ 28.49 | $ 37.94 | $ 36.67 | $ 84.40 | $ 53.70 | $ 34.50 |
Market value, end of period | $ 28.44 | $ 38.00 | $ 36.61 | $ 84.35 | $ 53.70 | $ 34.58 |
Total Return at Net Asset Value(2) | (24.93)% | 3.46% | (56.27)% | 58.48% | 60.41% | 19.87% |
Total Return at Market Value(2) | (25.16)% | 3.80% | (56.32)% | 58.39% | 60.05% | 20.00% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $1,655,008 | $2,496,662 | $2,780,026 | $8,588,014 | $1,589,856 | $465,966 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.75%(3) | 0.75% | 0.75% | 0.75% | 0.75% | 0.75% |
Net investment loss | (0.72)%(3) | (0.70)% | (0.62)% | (0.28)% | (0.73)% | (0.63)% |
Portfolio turnover rate(4) | 10% | 28% | 51% | 45% | 50% | 64% |
See accompanying Notes to Financial Statements.
32
Table of Contents
Financial Highlights ARK Autonomous Technology & Robotics ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 58.83 | $ 56.11 | $ 81.12 | $ 52.69 | $ 33.05 | $ 34.93 |
Net investment loss(1) | (0.08) | (0.16) | (0.30) | (0.33) | (0.13) | (0.13) |
Net realized and unrealized gain (loss) on investments | (6.26) | 2.88 | (24.10) | 29.42 | 19.77 | (0.91) |
Total gain (loss) from investment operations | (6.34) | 2.72 | (24.40) | 29.09 | 19.64 | (1.04) |
Distributions to shareholders: | | | | | | |
Net realized gains | — | — | (0.61) | (0.66) | — | (0.84) |
Total distributions | — | — | (0.61) | (0.66) | — | (0.84) |
Net asset value, end of period | $ 52.49 | $ 58.83 | $ 56.11 | $ 81.12 | $ 52.69 | $ 33.05 |
Market value, end of period | $ 52.45 | $ 58.86 | $ 56.07 | $ 81.18 | $ 52.78 | $ 33.06 |
Total Return at Net Asset Value(2) | (10.78)% | 4.85% | (30.27)% | 55.31% | 59.43% | (2.66)% |
Total Return at Market Value(2) | (10.89)% | 4.98% | (30.38)% | 55.17% | 59.65% | (2.84)% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $929,010 | $1,170,658 | $1,211,939 | $2,806,640 | $447,887 | $166,897 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.75%(3) | 0.75% | 0.75% | 0.75% | 0.75% | 0.75% |
Net investment loss | (0.31)%(3) | (0.32)% | (0.42)% | (0.41)% | (0.34)% | (0.39)% |
Portfolio turnover rate(4) | 7% | 21% | 54% | 86% | 71% | 54% |
See accompanying Notes to Financial Statements.
33
Table of Contents
Financial Highlights ARK Innovation ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 50.42 | $ 45.14 | $ 119.91 | $ 80.37 | $ 48.36 | $ 44.51 |
Net investment loss(1) | (0.16) | (0.30) | (0.60) | (0.75) | (0.38) | (0.30) |
Net realized and unrealized gain (loss) on investments | (4.82) | 5.58 | (73.39) | 42.33 | 32.58 | 5.32 |
Total gain (loss) from investment operations | (4.98) | 5.28 | (73.99) | 41.58 | 32.20 | 5.02 |
Distributions to shareholders: | | | | | | |
Net realized gains | — | — | (0.78) | (2.04) | (0.19) | (1.17) |
Total distributions | — | — | (0.78) | (2.04) | (0.19) | (1.17) |
Net asset value, end of period | $ 45.44 | $ 50.42 | $ 45.14 | $ 119.91 | $ 80.37 | $ 48.36 |
Market value, end of period | $ 45.41 | $ 50.45 | $ 45.13 | $ 120.00 | $ 80.37 | $ 48.46 |
Total Return at Net Asset Value(2) | (9.89)% | 11.71% | (62.04)% | 51.65% | 66.82% | 12.14% |
Total Return at Market Value(2) | (9.99)% | 11.79% | (62.08)% | 51.76% | 66.47% | 12.27% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $7,504,248 | $9,295,353 | $9,336,819 | $22,495,429 | $6,132,599 | $1,731,253 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.75%(3) | 0.75% | 0.75% | 0.75% | 0.75% | 0.75% |
Net investment loss | (0.74)%(3) | (0.74)% | (0.75)% | (0.63)% | (0.70)% | (0.67)% |
Portfolio turnover rate(4) | 15% | 26% | 55% | 71% | 80% | 80% |
See accompanying Notes to Financial Statements.
34
Table of Contents
Financial Highlights ARK Next Generation Internet ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 67.23 | $ 54.55 | $ 147.37 | $ 99.48 | $ 52.32 | $ 55.10 |
Net investment loss(1) | (0.23) | (0.37) | (0.81) | (0.98) | (0.45) | (0.33) |
Net realized and unrealized gain (loss) on investments | 2.55 | 13.05 | (88.70) | 50.76 | 47.61 | 3.09 |
Total gain (loss) from investment operations | 2.32 | 12.68 | (89.51) | 49.78 | 47.16 | 2.76 |
Distributions to shareholders: | | | | | | |
Net realized gains | — | — | (3.31) | (1.89) | — | (5.54) |
Total distributions | — | — | (3.31) | (1.89) | — | (5.54) |
Net asset value, end of period | $ 69.55 | $ 67.23 | $ 54.55 | $ 147.37 | $ 99.48 | $ 52.32 |
Market value, end of period | $ 69.57 | $ 67.31 | $ 54.48 | $ 147.55 | $ 99.49 | $ 52.48 |
Total Return at Net Asset Value(2) | 3.44% | 23.25% | (61.95)% | 50.06% | 90.13% | 7.49% |
Total Return at Market Value(2) | 3.36% | 23.55% | (62.04)% | 50.24% | 89.58% | 7.80% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $1,523,036 | $1,650,511 | $1,456,499 | $5,813,640 | $1,920,045 | $431,660 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.75%(3) | 0.75% | 0.75% | 0.75% | 0.75% | 0.75% |
Net investment loss | (0.73)%(3) | (0.74)% | (0.75)% | (0.69)% | (0.68)% | (0.63)% |
Portfolio turnover rate(4) | 30% | 33% | 76% | 120% | 93% | 92% |
See accompanying Notes to Financial Statements.
35
Table of Contents
Financial Highlights ARK Fintech Innovation ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | For the Period February 4, 2019(1) through July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 24.16 | $ 17.91 | $ 50.67 | $ 36.18 | $ 22.84 | $ 20.00 |
Net investment loss(2) | (0.06) | (0.10) | (0.24) | (0.30) | (0.10) | (0.03) |
Net realized and unrealized gain (loss) on investments | 1.47 | 6.35 | (32.52) | 14.97 | 13.74 | 2.87 |
Total gain (loss) from investment operations | 1.41 | 6.25 | (32.76) | 14.67 | 13.64 | 2.84 |
Distributions to shareholders: | | | | | | |
Net realized gains | — | — | — | (0.18) | (0.30) | — |
Total distributions | — | — | — | (0.18) | (0.30) | — |
Net asset value, end of period | $ 25.57 | $ 24.16 | $ 17.91 | $ 50.67 | $ 36.18 | $ 22.84 |
Market value, end of period | $ 25.54 | $ 24.20 | $ 17.88 | $ 50.68 | $ 36.26 | $ 22.86 |
Total Return at Net Asset Value(3) | 5.83% | 34.92% | (64.66)% | 40.58% | 60.36% | 14.21% |
Total Return at Market Value(3) | 5.54% | 35.35% | (64.72)% | 40.29% | 60.59% | 14.30% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $1,029,069 | $1,088,289 | $936,432 | $3,610,269 | $347,337 | $74,233 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.75%(4) | 0.75% | 0.75% | 0.75% | 0.75% | 0.75%(4) |
Net investment loss | (0.54)%(4) | (0.56)% | (0.65)% | (0.60)% | (0.40)% | (0.24)%(4) |
Portfolio turnover rate(5) | 11% | 26% | 75% | 78% | 55% | 22% |
See accompanying Notes to Financial Statements.
36
Table of Contents
Financial Highlights ARK Space Exploration & Innovation ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | For the Period March 30, 2021(1) through July 31, 2021 |
Per Share Data: | | | | |
Net asset value, beginning of period | $ 15.57 | $ 14.93 | $ 20.35 | $ 20.00 |
Net investment loss(2) | (0.01) | (0.01) | (0.03) | (0.02) |
Net realized and unrealized gain (loss) on investments | (1.29) | 0.65 | (5.39) | 0.37 |
Total gain (loss) from investment operations | (1.30) | 0.64 | (5.42) | 0.35 |
Total distributions | — | — | — | — |
Net asset value, end of period | $ 14.27 | $ 15.57 | $ 14.93 | $ 20.35 |
Market value, end of period | $ 14.27 | $ 15.59 | $ 14.93 | $ 20.34 |
Total Return at Net Asset Value(3) | (8.37)% | 4.27% | (26.64)% | 1.77% |
Total Return at Market Value(3) | (8.47)% | 4.42% | (26.60)% | 1.70% |
Ratios/Supplemental Data: | | | | |
Net assets, end of period (000’s omitted) | $249,665 | $298,938 | $319,536 | $607,553 |
Ratio to average net assets of: | | | | |
Expenses, prior to expense waivers and reimbursements | 0.75%(4) | 0.75% | 0.75% | 0.75%(4) |
Expenses, net of expense waivers and reimbursements | 0.72%(4) | 0.71% | 0.70% | 0.71%(4) |
Net investment loss | (0.13)%(4) | (0.10)% | (0.18)% | (0.26)%(4) |
Portfolio turnover rate(5) | 5% | 8% | 41% | 46% |
See accompanying Notes to Financial Statements.
37
Table of Contents
Financial Highlights The 3D Printing ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 24.45 | $ 23.15 | $ 38.04 | $ 22.28 | $ 22.04 | $ 24.22 |
Net investment income (loss)(1) | 0.01 | (0.00)(2) | (0.05) | 0.00(2) | (0.00)(2) | (0.01) |
Net realized and unrealized gain (loss) on investments | (2.38) | 1.30 | (14.84) | 15.76 | 0.25 | (2.01) |
Total gain (loss) from investment operations | (2.37) | 1.30 | (14.89) | 15.76 | 0.25 | (2.02) |
Distributions to shareholders: | | | | | | |
Net investment income | — | — | (0.00)(2) | — | (0.01) | — |
Net realized gains | — | — | — | — | — | (0.16) |
Total distributions | — | — | (0.00) | — | (0.01) | (0.16) |
Net asset value, end of period | $ 22.08 | $ 24.45 | $ 23.15 | $ 38.04 | $ 22.28 | $ 22.04 |
Market value, end of period | $ 21.93 | $ 24.43 | $ 23.16 | $ 38.00 | $ 22.16 | $ 22.25 |
Total Return at Net Asset Value(3) | (9.70)% | 5.61% | (39.14)% | 70.76% | 1.15% | (8.25)% |
Total Return at Market Value(3) | (10.23)% | 5.48% | (39.05)% | 71.48% | (0.34)% | (7.76)% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $141,333 | $185,855 | $209,550 | $515,504 | $41,217 | $39,672 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.66%(4) | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% |
Net investment loss | 0.08%(4) | (0.01)% | (0.15)% | 0.00%(5) | 0.00%(5) | (0.04)% |
Portfolio turnover rate(6) | 21% | 45% | 37% | 59% | 37% | 51% |
See accompanying Notes to Financial Statements.
38
Table of Contents
Financial Highlights ARK Israel Innovative Technology ETF For a share outstanding throughout each period presented. | | |
| Six Months Ended January 31, 2024 (Unaudited) | Year Ended July 31, 2023 | Year Ended July 31, 2022 | Year Ended July 31, 2021 | Year Ended July 31, 2020 | Year Ended July 31, 2019 |
Per Share Data: | | | | | | |
Net asset value, beginning of period | $ 20.09 | $ 19.37 | $ 30.26 | $ 25.00 | $ 20.54 | $ 20.85 |
Net investment income (loss)(1) | (0.01) | (0.00)(2) | (0.04) | 0.05 | (0.03) | 0.08 |
Net realized and unrealized gain (loss) on investments | (0.54) | 0.72 | (10.75) | 5.21 | 4.97 | 0.18 |
Total gain (loss) from investment operations | (0.55) | 0.72 | (10.79) | 5.26 | 4.94 | 0.26 |
Distributions to shareholders: | | | | | | |
Net investment income | — | — | (0.10) | — | (0.48) | (0.57) |
Total distributions | — | — | (0.10) | — | (0.48) | (0.57) |
Net asset value, end of period | $ 19.54 | $ 20.09 | $ 19.37 | $ 30.26 | $ 25.00 | $ 20.54 |
Market value, end of period | $ 19.37 | $ 20.07 | $ 19.36 | $ 30.15 | $ 24.74 | $ 20.64 |
Total Return at Net Asset Value(3) | (2.73)% | 3.72% | (35.79)% | 21.06% | 24.31% | 1.57% |
Total Return at Market Value(3) | (3.49)% | 3.67% | (35.57)% | 21.87% | 22.41% | 1.20% |
Ratios/Supplemental Data: | | | | | | |
Net assets, end of period (000’s omitted) | $106,486 | $99,934 | $118,134 | $283,716 | $48,123 | $19,512 |
Ratio to average net assets of: | | | | | | |
Expenses | 0.49%(4) | 0.49% | 0.49% | 0.49% | 0.49% | 0.49% |
Net investment income (loss) | (0.12)%(4) | (0.02)% | (0.15)% | 0.15% | (0.14)% | 0.37% |
Portfolio turnover rate(5) | 21% | 51% | 58% | 88% | 86% | 57% |
See accompanying Notes to Financial Statements.
39
Table of Contents
Notes to Financial Statements January 31, 2024 (Unaudited) | | |
1. Organization
ARK ETF Trust (“Trust”) is an open-end management investment company registered under the Investment Company Act of 1940, as amended (“1940 Act”) and applies the specialized accounting and reporting guidance in U.S. Generally Accepted Accounting Principles (U.S. GAAP). The Trust was organized as a Delaware statutory trust on June 7, 2013. The Trust consists of eight (8) investment portfolios: ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, ARK Space Exploration & Innovation ETF, The 3D Printing ETF, and ARK Israel Innovative Technology ETF (each, a “Fund” and collectively, “Funds”). Each Fund is classified as a non-diversified management investment company under the 1940 Act.
The investment objective of the ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF is long-term growth of capital. The 3D Printing ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Total 3D-Printing Index. The ARK Israel Innovative Technology ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israel Innovation Index. There can be no assurance that the Funds will achieve their respective investment objectives.
The Trust’s fiscal and tax reporting year ends July 31.
2. Significant Accounting Policies
These financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which require management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amount of increase and decrease in net assets from operations during the fiscal period. Actual amounts could differ from these estimates. The Trust is an investment company and follows the investment company accounting standards and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standard Codification (“ASC”) Topic 946, “Financial Services — Investment Companies”. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative guidance for SEC registrants. The following summarizes the significant accounting policies of the Funds:
Investment Valuation
The values of each Fund’s securities that are traded on a securities market are based on such securities’ closing prices on the principal market on which the securities are traded. Such valuations would typically be categorized as Level 1 in the fair value hierarchy. If a security’s market price is not readily available or does not otherwise accurately reflect the market value of such security, the security will be fair valued by the Adviser, which was selected by the Board of Trustees of the Trust (“Board of Trustees”) as valuation designee, to provide such fair values in accordance with the Adviser’s valuation policies and procedures that were reviewed by, and subject to the oversight of, the Board of Trustees. Each Fund may use fair value pricing in a variety of circumstances, including but not limited to, situations when the value of a Fund’s security has been materially affected by events occurring after the close of the market on which such security is principally traded (such as a corporate action or other news that may materially affect the price of such security) or trading in such security has been suspended or halted. Such valuations would typically be categorized as Level 2 or Level 3 in the fair value hierarchy. Fair value pricing involves subjective judgments and it is possible that a fair value determination for a security could be materially different than the value that could be realized upon the sale of such security. Investments in money market funds are valued at their NAV as of the close of each business day. Exchange-traded funds are valued at their last sale or official closing price on the principal market.
Investment Transactions
Investment transactions are accounted for on the trade date. Realized gains and losses on sales of investment securities are calculated using the identified cost method. Dividend income is recognized on the ex-dividend date, except for certain foreign dividends that may be recorded as soon as such information becomes available. Interest income and expenses are recognized on an accrual basis.
Dividend Distributions
Distributions to shareholders are recorded on the ex-dividend date and are determined in accordance with federal income tax regulations, which may differ from U.S. GAAP. Each Fund distributes all or substantially all of its net investment income to shareholders in the form of dividends. Net realized capital gains are distributed to shareholders as capital gain distributions. Net investment income, if any, and net capital gains, if any, are typically distributed to shareholders at least annually. Dividends may be declared and paid more frequently to improve index tracking or to comply with the distribution requirements of the Internal Revenue Code.
40
Table of Contents
Notes to Financial Statements (continued) January 31, 2024 (Unaudited) | | |
Currency Translation
Assets and liabilities, including investment securities, denominated in currencies other than U.S. dollars are translated into U.S. dollars at the exchange rates supplied by one or more pricing vendors on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the exchange rates on the dates of such transactions.
The effects of changes in exchange rates on investment securities are included with the net realized gain or loss and net unrealized appreciation or depreciation on investments in each Fund’s statement of operations. The realized gain or loss and unrealized appreciation or depreciation resulting from all other transactions denominated in currencies other than U.S. dollars are disclosed separately.
Wholly-owned Subsidiary
ARK Next Generation Internet ETF gains exposure to cryptocurrency through investments in the ARK Next Generation Internet (Cayman) Fund, a wholly-owned subsidiary of the Fund organized under the laws of the Cayman Island (the “Subsidiary”). The Subsidiary is advised by the Adviser, and has the same investment objective as ARK Next Generation Internet ETF. All intercompany transactions and balances have been eliminated in consolidation.
3. Management and Other Agreements
Management
The ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF, each pay the Adviser a fee calculated daily and payable monthly at an annual rate (stated as a percentage of the average daily net assets of the Fund) of 0.75% (“Management Fee”) in return for providing investment management and supervisory services under a comprehensive unitary structure. The 3D Printing ETF pays the Adviser a Management Fee of 0.65% in return for providing investment management and supervisory services under a comprehensive unitary structure. The ARK Israel Innovative Technology ETF pays the Adviser a Management Fee of 0.48% in return for providing investment management and supervisory services under a comprehensive unitary structure. Subject to the oversight of the Board, the Adviser provides investment management services to each Fund and provides, or causes to be furnished, all supervisory and other services reasonably necessary for the operation of each Fund and also bears the costs of trustee fees and various third-party services required by the Funds, including administration, certain custody, audit, legal, transfer agency, and printing costs. In addition to the Management Fee, each Fund bears other fees and expenses, such as taxes and governmental fees, brokerage fees, commissions and other transaction expenses, certain foreign custodial fees and expenses, costs of borrowing money, including interest expenses, and extraordinary expenses (such as litigation and indemnification expenses).
The Adviser has agreed to reduce their Management Fee for the ARK Space Exploration & Innovation ETF as a result of investing in The 3D Printing ETF. As such, the Management Fees in the Statement of Operations have been reduced by $42,125. The Adviser has also agreed to waive or credit a portion of the Management Fee in an amount equal to any net fees received by the Adviser for the ARK Next Generation Internet ETF as a result of investing in ARK 21Shares Bitcoin ETF. The Adviser has not received any net fees for the six-month period ending January 31, 2024.
Administrator, Custodian, Transfer Agent and Accounting Agent
The Bank of New York Mellon is the administrator for the Funds, the custodian of the Funds’ assets and also provides transfer agency, fund accounting and various administrative services to the Funds (in each capacity, “Administrator,” “Custodian,” “Transfer Agent” or “Accounting Agent”). The Bank of New York Mellon is a subsidiary of The Bank of New York Mellon Corporation, a financial holding company.
Distribution
Foreside Fund Services, LLC serves as the Funds’ distributor (“Distributor”). The Trust has adopted a distribution and service plan (“Rule 12b-1 Plan”) pursuant to Rule 12b-1 under the 1940 Act. Under the Rule 12b-1 Plan, each Fund is authorized to pay distribution fees in connection with the sale and distribution of its shares and pay service fees in connection with the provision of ongoing services to shareholders. To date, the Rule 12b-1 Plan has not been implemented for the Funds and there is no current intention to implement the Rule 12b-1 Plan.
Board of Trustees
Each Independent Trustee receives an annual retainer fee of $230,000 for services provided as a Trustee of the Trust, plus out-of-pocket expenses related to attendance at Board and Committee Meetings. The Chairs of the Board and of the Audit Committee each also receive an additional annual retainer fee of $60,000 and $20,000, respectively, for their service as such. Annual Trustee fees may be reviewed periodically and changed by the Trust’s Board.
41
Table of Contents
Notes to Financial Statements (continued) January 31, 2024 (Unaudited) | | |
4. Creation and Redemption Transactions
As of January 31, 2024, there were an unlimited number of shares of beneficial interest without par value authorized by the Trust. Individual shares of a Fund may only be purchased and sold at market prices on a national securities exchange through a broker-dealer. Such transactions may be subject to customary commission rates imposed by the broker-dealer, and market prices for a Fund’s shares may be at, above or below its net asset value (“NAV”) depending on the premium or discount at which the Fund’s shares trade.
Each Fund issues and redeems shares at its NAV only in a large specified number of shares each called a “Creation Unit,” or multiples thereof, and only with “authorized participants” who have entered into contractual arrangements with the Distributor. A Creation Unit consists of 50,000 shares (25,000 shares with respect to the ARK Israel Innovative Technology ETF). Except when aggregated in Creation Units, shares of each Fund are not redeemable. Transactions in shares for each Fund are disclosed in detail in the Statements of Changes in Net Assets. The consideration for a purchase of Creation Units generally consists of the in-kind deposit of specified securities and an amount of cash or, as permitted or required by a Fund, of cash. A fixed transaction fee is imposed on each creation and redemption transaction. In addition, a variable charge for certain creation and redemption transactions may be imposed.
5. Investment Transactions
The cost of purchases and the proceeds from sales of investment securities (excluding in-kind subscriptions and redemptions and short-term investments) for the six months ended January 31, 2024 were as follows:
Fund | Purchases | Sales |
ARK Genomic Revolution ETF | $ 195,975,686 | $ 196,023,487 |
ARK Autonomous Technology & Robotics ETF | 71,506,845 | 75,117,259 |
ARK Innovation ETF | 1,155,628,711 | 1,174,319,615 |
ARK Next Generation Internet ETF | 433,574,456 | 438,209,902 |
ARK Fintech Innovation ETF | 108,339,185 | 106,637,069 |
ARK Space Exploration & Innovation ETF | 13,118,975 | 13,732,130 |
The 3D Printing ETF | 34,189,808 | 31,739,073 |
ARK Israel Innovative Technology ETF | 19,383,081 | 19,832,072 |
For the six months ended January 31, 2024, the cost of in-kind subscriptions and the proceeds from in-kind redemptions were as follows:
| In-Kind |
Fund | Subscriptions | Redemptions |
ARK Genomic Revolution ETF | $ 514,310,364 | $ 731,320,208 |
ARK Autonomous Technology & Robotics ETF | 2,921,210 | 118,030,387 |
ARK Innovation ETF | 4,752,698,332 | 5,646,750,758 |
ARK Next Generation Internet ETF | 170,114,679 | 326,550,187 |
ARK Fintech Innovation ETF | 30,628,608 | 128,985,296 |
ARK Space Exploration & Innovation ETF | — | 23,708,863 |
The 3D Printing ETF | — | 25,872,328 |
ARK Israel Innovative Technology ETF | 26,768,045 | 17,116,279 |
6. Federal Income Tax
Each Fund intends to continue to qualify as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended. If so qualified, a Fund will not be subject to federal income tax to the extent it distributes substantially all of its net investment income and net capital gains to its shareholders. U.S. GAAP provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements, and requires the evaluation of tax positions taken or expected to be taken in the course of preparing a Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the more-than-likely-than-not threshold would be recorded as a tax benefit or expense in the current year. Interest and penalties related to income taxes would be recorded as income tax expense. The Funds record a foreign tax reclaim receivable on the ex-dividend date if the tax reclaim is “more likely than not” to be sustained assuming examination by tax authorities. This determination is based on, among other things, a jurisdiction’s legal obligation to pay reclaims as well as payment history and market convention. The management of the Funds is required to analyze all open tax years (2020 − 2023), as defined by IRS statute of limitations, for all major jurisdictions, including federal tax authorities and certain state tax authorities. As of January 31, 2024, the Funds did not have a liability for any unrecognized tax benefits. The Funds have no examinations in progress and are not aware of any tax positions for which it is reasonably possible that the amounts of unrecognized tax benefits will significantly change in the next twelve months.
42
Table of Contents
Notes to Financial Statements (continued) January 31, 2024 (Unaudited) | | |
At January 31, 2024, the approximate cost of investments and net unrealized appreciation (depreciation) for federal income tax purposes was as follows:
Fund | Cost | Gross Unrealized Appreciation | Gross Unrealized Depreciation | Net Unrealized Appreciation (Depreciation) | |
ARK Genomic Revolution ETF | $ 5,401,086,967 | $ 41,602,075 | $ (3,718,564,708) | (3,676,962,633 | ) |
ARK Autonomous Technology & Robotics ETF | 1,434,631,417 | 96,301,843 | (594,424,286) | (498,122,443 | ) |
ARK Innovation ETF | 17,433,426,952 | 85,173,350 | (9,087,693,525) | (9,002,520,175 | ) |
ARK Next Generation Internet ETF | 2,795,907,797 | 82,106,104 | (1,263,516,541) | (1,181,410,437 | ) |
ARK Fintech Innovation ETF | 1,662,520,155 | 93,549,216 | (1,075,755,762) | (982,206,546 | ) |
ARK Space Exploration & Innovation ETF | 366,425,727 | 365,055,203 | (201,819,666) | 163,235,537 | |
The 3D Printing ETF | 204,597,378 | 38,202,491 | (189,236,722) | (151,034,231 | ) |
ARK Israel Innovative Technology ETF | 112,593,626 | 21,891,528 | (16,482,267) | 5,409,261 | |
The differences between book-basis and tax-basis components of net assets are primarily attributable to tax deferral of losses on wash sales, non-REIT income and basis adjustments, in-kind creation and redemption transactions, net operating losses, foreign currency gains and losses, passive foreign investment companies, grantor trust adjustments, and late year ordinary loss deferrals. Certain capital accounts in the financial statements have been adjusted for permanent book-tax differences. These adjustments have no impact on net asset values.
Under current tax regulations, capital losses on securities transactions realized after October 31 (“Post-October Losses”) and ordinary losses incurred after December 31 (“Late Year Ordinary Losses”) may be deferred and treated as occurring on the first business day of the following fiscal year. For the year ended July 31, 2023, the Funds incurred and elected to defer to August 1, 2023 Post-October Losses and Late Year Ordinary Losses as follows:
Fund | Late Year Ordinary Deferral | Capital Post-October Loss |
ARK Genomic Revolution ETF | $ (8,249,382) | $ — |
ARK Autonomous Technology & Robotics ETF | (1,882,520) | — |
ARK Innovation ETF | (32,533,949) | — |
ARK Next Generation Internet ETF | (5,404,327) | — |
ARK Fintech Innovation ETF | (2,711,581) | — |
ARK Space Exploration & Innovation ETF | (147,855) | — |
The 3D Printing ETF | (48,818) | — |
ARK Israel Innovative Technology ETF | (81,576) | — |
At July 31, 2023, for Federal income tax purposes, the Funds have capital loss carryforwards available as shown in the table below, to the extent provided by regulations, to offset future capital gains for an unlimited period. To the extent that these capital loss carryforwards are used to offset future capital gains, it is probable that the capital gains so offset will not be distributed to shareholders.
| Short-Term | Long-Term | Total Amount |
ARK Genomic Revolution ETF | $ 250,757,963 | $ 837,906,694 | $1,088,664,657 |
ARK Autonomous Technology & Robotics ETF | 18,186,873 | 260,347,957 | 278,534,830 |
ARK Innovation ETF | 1,042,848,686 | 1,573,266,388 | 2,616,115,074 |
ARK Next Generation Internet ETF | 251,556,319 | 510,982,724 | 762,539,043 |
ARK Fintech Innovation ETF | 570,104,221 | 434,174,811 | 1,004,279,032 |
ARK Space Exploration & Innovation ETF | 18,119,835 | 10,568,839 | 28,688,674 |
The 3D Printing ETF | 94,849,026 | 78,697,270 | 173,546,296 |
ARK Israel Innovative Technology ETF | 59,766,481 | 55,301,555 | 115,068,036 |
7. Indemnification Obligations
The Funds have a variety of indemnification obligations under contracts with their service providers. The Funds’ maximum exposure under these arrangements is unknown. However, the Funds have not had prior claims or losses pursuant to these contracts and expect the risk of loss to be remote.
43
Table of Contents
Notes to Financial Statements (concluded) January 31, 2024 (Unaudited) | | |
8. Investment Risks
The Funds’ prospectuses contain additional information regarding the risks associated with an investment in a Fund.
Concentration Risk: The ARK Autonomous Technology & Robotics ETF is concentrated in securities of issuers having their principal business activities in groups of industries in the industrials and information technology sectors, although it will not concentrate in any specific industry. The ARK Fintech Innovation ETF is concentrated in securities of issuers having their principal business activities in the communication, technology and financials group of industries. The ARK Genomic Revolution ETF is concentrated in securities of issuers having their principal business activities in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The ARK Next Generation Internet ETF is concentrated in securities of issuers having their principal business activities in the internet information provider and catalog and mail order house industry. The ARK Space Exploration & Innovation ETF is concentrated in securities of issuers having their principal business activities in groups of industries in the (i) industrials sector and (ii) information technology sector. The 3D Printing ETF and the ARK Israel Innovative Technology ETF may each invest 25% or more of the value of its respective net assets in securities of issuers in any one industry or group of industries if their respective indices. The Total 3-D Printing Index and The ARK Israeli Innovation Index, concentrate in such industry or group of industries. This concentration limit does not apply to securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities. The ARK Innovation ETF is not concentrated in any industry.
As of January 31, 2024, the ARK Genomic Revolution ETF had more than 25% of its assets invested in the biotechnology industry, the ARK Space Exploration & Innovation ETF had more than 25% of its assets invested in the aerospace & defense industry, and the ARK Israel Innovative Technology ETF had more than 25% of its assets invested in the software industry. To the extent a Fund’s holdings are concentrated in a particular industry or group of industries, adverse market conditions affecting those industries may have a more significant impact on the Fund than they would on a Fund investing in a broader range of securities and the value of the Fund’s shares may fluctuate more than shares of a fund investing in a broader range of securities.
Market Risk: The value of the Funds’ assets will fluctuate as the markets in which the Funds invests fluctuate. The value of the Funds’ investments may decline, sometimes rapidly and unpredictably, simply because of economic changes or other events, such as inflation (or expectations for inflation), deflation (or expectations for deflation), interest rates, global demand for particular products or resources, market instability, debt crises and downgrades, embargoes, tariffs, sanctions and other trade barriers, regulatory events, other governmental trade or market control programs and related geopolitical events. In addition, the value of the Funds’ investments may be negatively affected by the occurrence of global events such as war, military conflicts, acts of terrorism, social unrest, environmental disasters, natural disasters or events, recessions, supply chain disruptions, political instability, exchange trading suspensions and closures (including exchanges of the Funds’ underlying securities), infectious disease outbreaks or pandemics. For example, an outbreak of an infectious disease may negatively affect economies, markets and individual companies throughout the world, including those in which the Funds invest. The effects of this, or any future, pandemic to public health and business and market conditions, including exchange trading suspensions and closures, may have a significant negative impact on the performance of a Fund’s investments, increase a Fund’s volatility, negatively impact a Fund’s arbitrage and pricing mechanisms, exacerbate pre-existing political, social and economic risks to a Fund and negatively impact broad segments of businesses and populations. A Fund’s operations may be interrupted as a result, which may contribute to the negative impact on investment performance. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to a pandemic that affect the instruments in which a Fund invests, or the issuers of such instruments, in ways that could have a significant negative impact on the Fund’s investment performance. The ultimate impact of any pandemic and the extent to which the associated conditions and governmental responses impact a Fund will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
9. New Accounting Pronouncement
In June 2022, the FASB issued Accounting Standards Update (“ASU”) No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also introduce new disclosure requirements related to such equity securities. The ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within those fiscal years. Early adoption is permitted. Management has not yet elected to early adopt the new amendment, is continuously evaluating the new disclosure requirements and has currently determined that it is unlikely the ASU’s adoption will have a material impact on the Funds’ financial statements.
10. Subsequent Events
Subsequent events occurring after January 31, 2024 have been evaluated for potential impact to this Report through the date the Report was issued, and it has been determined that no additional events have occurred that require disclosure.
44
Table of Contents
Supplemental Information (Unaudited) | | |
Quarterly Portfolio Schedule. The ARK ETF Trust files with the Securities and Exchange Commission on Form N-PORT the complete schedule of portfolio holdings for each ARK ETF for the first and third quarters of each fiscal year. The ARK ETF Trust’s Forms N-PORT are available on the Securities and Exchange Commission’s website at www.sec.gov. Copies of the filings are available without charge, upon request, by calling (727) 810-8160. In addition, each ARK ETF’s current portfolio holdings are updated daily and are available on our website, www.ark-funds.com.
Proxy Voting Policies and Procedures. A description of ARK Investment Management LLC’s proxy voting policies and procedures, which are applicable to the ARK ETFs, is available without charge, upon request, by calling (727) 810-8160 collect or visiting our website at www.ark-funds.com or the Securities and Exchange Commission’s website at www.sec.gov.
Proxy Voting Record. The ARK ETFs file with the Securities and Exchange Commission their proxy voting records on Form N-PX for each 12 month period ending June 30. Form N-PX must be filed each year by August 31. The most recent Form N-PX or voting record information is available without charge, upon request, by calling (727) 810-8160 collect or visiting the Securities and Exchange Commission’s website at www.sec.gov.
Premium/Discount Information. Information about the difference between daily market prices on the secondary market for shares of each ARK ETF and the ARK ETF’s net asset value can be found on our website, www.ark-funds.com.
45
Table of Contents
Risks Involved with Investing in the Funds (Unaudited) | | |
This report should be read in conjunction with the Trust’s prospectus.
The principal risks of investing in the ARK ETFs include:
Disruptive Innovation Risk Companies that the Adviser believes create and capitalize on disruptive innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. A Fund may invest in a company that does not currently derive any revenue from disruptive innovations or technologies, and there is no assurance that a company will derive any revenue from disruptive innovations or technologies in the future.
Equity Securities Risk The value of the equity securities the Funds hold may fall due to general market and economic conditions, perceptions regarding the industries in which the issuers of securities the Funds hold participate or factors relating to specific companies in which the Funds invest (e.g., litigation or government regulation), among other factors. Equity securities may also be particularly sensitive to general movements in the stock market, and a decline in the broader market may affect the value of the Fund’s equity investments. The Funds may invest in stock of, warrants to purchase stock of, and other interests in special purpose acquisition companies (SPACs) or similar special purposes entities. A SPAC is a publicly traded company that raises investment capital for the purpose of acquiring or merging with an existing company. Investments in SPACs and similar entities are subject to a variety of risks beyond those associated with other equity securities. Because SPACs and similar entities do not have any operating history or ongoing business other than seeking acquisitions, the value of their securities is particularly dependent on the ability of the SPAC’s management to identify a merger target and complete an acquisition. Until an acquisition or merger is completed, a SPAC generally invests its assets, less a portion retained to cover expenses, in U.S. government securities, money market securities and cash and does not typically pay dividends in respect of its common stock. As a result, it is possible that an investment in a SPAC may lose value.
Foreign Securities Risk Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities such as risks of currency exchange rates, differences in foreign accounting and legal standards, the availability of less reliable financial information, and government restrictions on repatriation of capital. Geopolitical risks, including those arising from trade tension and/or the imposition of trade tariffs, terrorist activity or acts of civil or international hostility, are increasing. For instance, military conflict and escalating tensions between countries could result in geopolitical instability and adversely affect the global economy or specific markets. Strategic competition between the U.S. and China and resulting tensions have also contributed to uncertainty in the geopolitical and regulatory landscapes. Similarly, other events outside of the Trust’s control, including natural disasters, climate change-related events, pandemics (such as the COVID-19 pandemic) or health crises may arise from time to time and be accompanied by governmental actions that may increase international tension. Any such events and responses, including regulatory developments, may cause significant volatility and declines in the global markets, disproportionate impacts to certain industries or sectors, disruptions to commerce (including to economic activity, travel and supply chains), loss of life and property damage, and may adversely affect the global economy or capital markets and may cause the Trust’s assets to decline.
Israel Risk Because the Fund invests in securities of Israeli Companies, the Fund may be exposed to special risks and considerations. There may be less information concerning the securities of Israeli Companies available to the public than the securities of U.S. companies. There is also potential difficulty in obtaining or enforcing a court judgment, and the unique characteristics of securities of Israeli Companies and the Israel stock market may have a negative impact on the Fund. Any major hostilities involving Israel, including hostilities with neighboring countries, or the interruption or curtailment of trade between Israel and its present trading partners, could have a negative impact on the Fund. Shares and dividends of Israeli Companies are often Israeli new shekel (“ILS”) denominated. Changes in the relationship of the ILS to the U.S. dollar and other currencies could have a negative impact on the Fund. The government of Israel may change the way in which Israeli Companies are taxed, or may impose taxes on foreign investment. Such actions could have an adverse impact on the overall market for securities of Israeli Companies and on the Fund.
Concentration Risk The Fund’s assets may be concentrated in a particular industry or group of industries to the extent the Index concentrates in a particular industry or group of industries. If the Fund’s assets are concentrated in a particular industry or group of industries, the Fund will be subject to the risk that economic, political or other conditions that have a negative effect on that industry or group of industries will negatively impact the Fund to a greater extent than if the Fund’s assets were invested in a wider variety of industries.
Index Tracking Risk An Index Fund’s return may not track the performance of the Index for a number of reasons. For example, an Index Fund incurs a number of operating expenses not applicable to the applicable Index and incurs costs associated with buying and selling securities, especially when rebalancing the Index Fund’s securities holdings to reflect changes in the composition of the applicable Index. An Index Fund also bears the costs and risks associated with buying and selling securities while such costs and risks are not factored into the return of the applicable Index. When the Index Fund’s Index is rebalanced and the Index Fund in turn rebalances its portfolio to attempt to increase the correlation between the Index Fund’s portfolio and its applicable Index, any transaction costs and market exposure arising from such portfolio rebalancing will be borne directly by the Index Fund and its shareholders. Apart from scheduled rebalances, the Index provider or its agents may carry out additional ad hoc rebalances to the Index Fund’s applicable Index, which may increase the costs to and the tracking error risk of the Index Fund. In addition, the Index Fund may not be able to invest in certain securities included in the applicable Index or may not
46
Table of Contents
Risks Involved with Investing in the Funds (Unaudited) (continued) | | |
be able to invest in them in the exact proportions in which they are represented in the applicable Index, due to legal restrictions or limitations imposed by the governments of certain countries, potential adverse tax consequences or other regulatory reasons. The risk that the Index Fund may not track the performance of the applicable Index may be magnified during times of heightened market volatility or other unusual market conditions. A lack of liquidity may be due to various events, including markets events, economic conditions or investor perceptions. Illiquid securities may be difficult to value and their value may be lower than market price of comparable liquid securities, which would negatively affect the Index Fund’s performance. To the extent the Index Fund calculates its NAV based on “fair value” prices for certain securities and the value of the applicable Index is based on securities’ closing prices (i.e., the value of the Index is not based on “fair value” prices), the Index Fund’s ability to track the applicable Index may be adversely affected. For tax efficiency purposes, the Index Fund may sell certain securities to realize losses causing it to deviate from the applicable Index. Errors in the construction or calculation of the applicable Index may occur from time to time and any such errors may not be immediately identified and corrected by Solactive, which may have an adverse impact on the Index Fund and its shareholders.
Authorized Participants Concentration Risk A Fund has a limited number of financial institutions that may act as Authorized Participants (“APs”) on an agency basis (i.e., on behalf of other market participants). To the extent that those APs exit the business or are unable to process creation and/or redemption orders, and no other AP is able to step forward to create and redeem in either of these cases, Shares may possibly trade at a discount to net asset value (“NAV”). The AP risk may be heightened in the case of ETFs investing internationally because international ETFs often require APs to post collateral, which only certain APs are able to do.
Health Care Sector Risk Companies in the health care sector may be adversely affected by government regulations and government health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors.
Consumer Discretionary Risk The consumer discretionary sector may be affected by changes in domestic and international economies, exchange and interest rates, competition, consumers’ disposable income and consumer preferences, social trends and marketing campaigns.
CyberSecurity Risk: As the use of Internet technology has become more prevalent in the course of business, funds have become more susceptible to potential operational risks through breaches in cybersecurity. A breach in cybersecurity refers to both intentional and unintentional events that may cause the Fund to lose proprietary information, suffer data corruption or lose operational capacity. Such events could cause the Fund to incur regulatory penalties, reputational damage, additional compliance costs associated with corrective measures and/or financial loss. Cybersecurity breaches may involve unauthorized access to the Fund’s digital information systems through “hacking” or malicious software coding, but may also result from outside attacks such as denial-of-service attacks through efforts to make network services unavailable to intended users. In addition, cybersecurity breaches of the Fund’s third-party service providers, such as its administrator, transfer agent or custodian, or issuers in which the Fund invests, can also subject the Fund to many of the same risks associated with direct cybersecurity breaches. While the Fund has established business continuity plans and risk management systems designed to reduce the risks associated with cybersecurity, there are inherent limitations in such plans and systems. Additionally, there is no guarantee that such efforts will succeed, especially because the Fund does not directly control the cybersecurity systems of issuers or third-party service providers.
Industrials Sector Risk Companies in the industrials sector may be adversely affected by changes in government regulation (such as through the imposition or removal of tariffs), world events, economic conditions, environmental damages, product liability claims and exchange rates.
Information Technology Sector Risk Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. The markets in which many information technology companies compete face rapidly evolving industry standards and government regulations, in the U.S. and abroad, including potential anti-trust actions, potential anti-trust actions, fines and penalties, and frequent new service and product announcements, introductions and enhancements, and changing customer demands.
Communications Sector Risk Communication companies are particularly vulnerable to the potential obsolescence of products and services due to technological advancement and the innovation of competitors. Companies in the communications sector may also be affected by other competitive pressures, such as pricing competition, as well as research and development costs, substantial capital requirements and government regulation.
Financial Technology Sector Risk Companies in the financial technology (“FinTech”) sector that are developing financial technologies that seek to disrupt or displace established financial institutions generally face competition from much larger and more established firms. FinTech companies may not currently derive any revenue, and there is no assurance that such companies will derive any revenue from innovative technologies in the future.
47
Table of Contents
Risks Involved with Investing in the Funds (Unaudited) (concluded) | | |
Cryptocurrency Investment Risk ARKW may have exposure to cryptocurrency, such as bitcoin and Ether, indirectly through an investment in ARK 21Shares Bitcoin ETF, ProShares Bitcoin Strategy ETF, and ARK 21Shares Active Bitcoin Futures ETF that will experience any associated volatility of the underlying crytocurrency. Additionally, the Funds may have exposure to cryptocurrency indirectly through investments in public companies that are active in the cryptocurrency markets. The Funds’ exposure to cryptocurrencies may change over time and, accordingly, such exposure may not always be present in the Funds’ portfolios. Cryptocurrencies such as bitcoin are not “fiat” currencies of any central bank or government and currently are not subject to the authority of any central bank or government authority and are therefore not backed by any government, and regulatory and tax treatment of cryptocurrencies continues to develop.
Non-Diversified Risk As a non-diversified investment company, a Fund is subject to the risk that it will be more volatile than a diversified fund because the Fund may invest a relatively higher proportion of its assets in a relatively smaller number of issuers or may invest a larger proportion of its assets in a single issuer. As a result, the gains and losses on a single investment may have a greater impact on a Fund’s NAV and may make the Fund more volatile than more diversified funds.
Market Trading Risk Each Fund faces numerous market trading risks, including disruptions to the creation and redemption processes of the Fund, losses from trading in secondary markets, the existence of extreme market volatility, the potential lack of an active trading market for the Fund’s shares due to market stress, or trading halts impacting the Shares or the Fund’s underlying securities, which may result in the Fund’s shares trading at a significant premium or discount to NAV. Please see the ARK ETFs’ current prospectuses for more detailed descriptions of the risks of investing in the ARK ETFs.
Subsidiary Risk ARKW gains exposure to cryptocurrency through investments in the Subsidiary. By investing in the Subsidiary, the ARKW is indirectly exposed to the risks associated with the Subsidiary’s investments. The investments held by the Subsidiary are generally similar to those that are permitted to be held by ARKW and are subject to the same risks that apply to similar investments if held directly by ARKW. There can be no assurance that the investment objective of ARKW or the Subsidiary will be achieved. The Subsidiary is not registered under the 1940 Act, and generally is not subject to all the investor protections of the 1940 Act. In addition, changes in the laws of the United States and/or the Cayman Islands could result in the inability of ARKW and/or the Subsidiary to operate as intended and could adversely affect ARKW. Changes in the laws of the United States and/or the Cayman Islands could adversely affect the performance of ARKW and/or the Subsidiary.
Tax Risk ARKW may seek to gain exposure to cryptocurrency through investments in the Subsidiary. Treasury regulations generally treat ARKW’s income inclusion with respect to the Subsidiary as qualifying income either if (A) there is a current distribution out of the earnings and profits of the Subsidiary that are attributable to such income inclusion or (B) such inclusion is derived with respect to ARKW’s business of investing in stock, securities, or currencies. The tax treatment of ARKW’s investments in the Subsidiary may be adversely affected by future legislation, court decisions, Treasury Regulations and/or guidance issued by the IRS that could affect whether income derived from such investments is “qualifying income” under Subchapter M of the Internal Revenue Code, or otherwise affect the character, timing and/or amount of ARKW’s taxable income or any gains and distributions made by ARKW. No assurances can be provided that the IRS would not be able to successfully assert that ARKW’s income from investments in the Subsidiary was not “qualifying income,” in which case ARKW would fail to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code if over 10% of its gross income was derived from these investments. If ARKW failed to qualify as a regulated investment company, it would be subject to federal and state income tax on all of its taxable income at regular corporate tax rates with no deduction for any distributions paid to shareholders, which would significantly adversely affect the returns to, and could cause substantial losses for, fund shareholders. The Cayman Islands does not currently impose any income, corporate or capital gains tax, estate duty, inheritance tax, gift tax or withholding tax on the Subsidiary. If Cayman Islands law changes such that the Subsidiary must pay Cayman Islands taxes, Fund shareholders would likely suffer decreased investment returns.
48
Table of Contents
General Information (Unaudited) | | |
Investment Adviser
ARK Investment Management LLC
200 Central Avenue
St. Petersburg, FL 33701
Administrator, Custodian, Transfer Agent, and Accounting Agent
The Bank of New York Mellon
240 Greenwich Street
New York, NY 10286
Distributor
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, ME 04101
Independent Registered Public Accounting Firm
Ernst & Young LLP
One Manhattan West
New York, NY 10001
Table of Contents
This report is submitted for the general information of the shareholders of each Fund. It is not authorized for distribution to prospective investors unless preceded or accompanied by an effective prospectus, which includes information regarding the Funds’ risks, objectives, fees and expenses, experience of their management, and other information.
ARK Invest | 200 Central Avenue, St. Petersburg, FL 33701 | 727.810.8160 | info@ark-invest.com | ark-funds.com
Table of Contents
(b) Not applicable.
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
The Registrant’s Board has an Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act (15 U.S.C. 78c(a)(58)(A)) consisting of three Independent Trustees. Messrs. Chichester and Zack and Ms. DeRemer currently serve as members of the Audit Committee. Mr. Chichester is the Chairman of the Audit Committee.
Item 6. Investments.
(a) Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1(a) of this form.
(b) Not applicable.
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s board of trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 11. Controls and Procedures.
(a) As of a date within 90 days of the filing date of this Form N-CSR, the registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c))) are effective, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)).
(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Table of Contents
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
(a) Not applicable.
(b) Not applicable.
Item 19. Exhibits.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.
(a)(2)(1) Not applicable.
(a)(2)(2) Not applicable.
(b) Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | | ARK ETF Trust | | | | |
By (Signature and Title)* | | /s/ Catherine D. Wood | | | | |
| | Catherine D. Wood, Chief Executive Officer and | | |
| | Chief Investment Officer | | |
| | (principal executive officer) | | | | |
Date | | April 2, 2024 | | | | | | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)* | | /s/ Catherine D. Wood | | | | |
| | Catherine D. Wood, Chief Executive Officer and | | |
| | Chief Investment Officer | | |
| | (principal executive officer) | | | | |
Date | | April 2, 2024 | | | | | | |
By (Signature and Title)* | | /s/ William C. Cox | | | | |
| | William C. Cox, Treasurer and Chief Financial Officer | | |
| | (principal financial officer) | | |
Date | | April 2, 2024 | | | | | | |
__________
* Print the name and title of each signing officer under his or her signature.